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Ubiquitination is a post-translational modification that involves the covalent attachment of 
one or several ubiquitin (Ub) molecules to a substrate protein. Initially, it was considered as 
a mechanism to control the abundance of proteins in the cell. These days it is evident that 
ubiquitination fulfils many other roles, being involved in a wide array of cellular functions. 
Among the enzymes that participate in the ubiquitination pathway, E3 ligases stand out 
since they define the specificity of the reaction and determine which type of Ub chains is 
attached to the substrate. This in turn, defines the fate of the substrate inside the cell. 
From the approximately 600 E3 ligases that the human genome encodes, 28 belong to 
the HECT (Homologous to the E6-AP C terminus) family of E3s, a particular group that has 
intrinsic catalytic activity by forming a thioester intermediate before Ub is transferred to 
the substrate. Numerous studies associate aberrant expression or mutations in HECT-type 
E3s with various human diseases including cancer, where they can act both as 
oncoproteins or tumor suppressors. It is thus of utmost importance to understand in detail 
catalytic mechanism and the regulation of HECT-type Ub ligases. 
Nedd4-family Ub ligases are a subgroup of HECT E3s that contain an N-terminal C2 
domain, two to four central WW domains and a C-terminal HECT domain. For a few 
members of this family it has been shown that they are kept in an auto-inhibited 
conformation that prevents untimely ubiquitination. However, the mechanistic details were 
not clear. Here, I studied the basis of C2-mediated auto-inhibition in two members of the 
Nedd4-family: Smurf2 and Nedd4. Using NMR spectroscopy and biochemical assays I 
found that binding of the C2 domain to the HECT domain impairs E2-E3 transthiolation, 
by locking the enzyme in an incompetent catalytic conformation. Moreover, C2 binding 
abolishes non-covalent interaction of the HECT domain with Ub, which is known to be an 
important step in Ub chain elongation. 
The Smurf1 E3 ligase is an E3 that shares more that 70% sequence identity with Smurf2. 
However, it was not clear whether Smurf1 is regulated by the same C2:HECT auto-
inhibitory mechanism as Smurf2. My studies revealed that although the C2:HECT binding 
surface is conserved between Smurf1 and Smurf2 and the Smurf1 C2 domain inhibits 
HECT activity in trans, the full length (FL) enzyme is constitutively active. I was able to show 
that this strikingly difference between Smurf1 and Smurf2 is due to the lack of the WW1 
domain in Smurf1, that plays a role in enhancing C2:HECT binding affinity. 
Finally, Ca2+-mediated release of the C2 domain is as a mechanism for Nedd4 E3 ligase 
activation. I showed that the Nedd4 C2 domain binds calcium through the conserved 
calcium binding region and thereby competes with HECT domain interaction. However, I 
could also show that other members of the Nedd4 family such as Smurf1, Smurf2 and the 





mediated release of the C2 domain from the HECT domain as an activation mechanism is 
likely restricted to a small subset of Nedd4 proteins. 
Overall, Nedd4-family enzymes play key roles in the establishment and regulation of both 
developmental and carcinogenic processes. Hence, profound studies of the catalytic 
mechanisms and detailed analysis of protein-specific regulation of these enzymes as 
presented in this thesis, contribute significantly to the understanding of HECT ligases but 


























Ubiquitinierung ist eine posttranslationale Modifikation, die mit der kovalenten 
Übertragung eines oder mehrerer Ubiquitinmoleküle auf ein Substratprotein einhergeht. 
Ursprünglich wurde angenommen, dass es sich hierbei um einen Mechanismus zur 
Mengenkontrolle von Proteinen in der Zelle handelt. Heutzutage gilt es allerdings als 
erwiesen, dass die Ubiquitinierung eine Vielzahl an Funktionen erfüllt, die in einer großen 
Zahl von zellularen Prozessen eine wichtige Rolle spielen. Unter den Enzymen, die 
während der Ubiquitinierung involviert sind, spielen die E3-Ligasen eine besonders 
wichtige Rolle, da sie die Reaktionsspezifität festlegen und somit den Ubiquitinkettentyp 
bestimmen. Der Ubiquitinkettentyp wiederum bestimmt das Schicksal des Substratproteins. 
Im menschlichen Genom sind etwa 600 E3-Ligase kodiert von denen 28 zur Familie der 
HECT-Ligasen (Homologous tot he E6AP C terminus) gehören. Alle Mitglieder dieser 
Genfamilie besitzen eine intrinsische katalytische Aktivität, da sie mit Ubiquitin (Ub) als 
Reaktionsintermediat einen Thioester ausbilden, bevor es auf das Substrat übertragen 
wird. In einer Vielzahl von Studien assoziieren eine fehlerhafte Expression oder Mutationen 
von HECT E3-Ligasen mit verschiedenen Krankheiten wie z.B. Krebs wobei sie sowohl als 
Onkoproteine als auch Tumorsupressoren auftreten können. Deshalb ist es von äußerster 
Wichtigkeit, dass die Details des Katalysemechanismus und der Regulation der HECT-
Ubiquitin-Ligasen untersucht und verstanden werden.  
Die Ub-Ligasen der Nedd4-Familie sind eine Untergruppe der HECT-E3-Ligasen und 
bestehen aus einer N-terminalen C2-Domäne, zwei bis vier WW-Domänen und einer C-
terminalen HECT-Domäne. Für einige Mitglieder dieser Genfamilie wurde bereits gezeigt, 
dass sie in einer autoinhibitorischen Konformation vorliegen die schlussendlich die 
Ubiquitinierungsreaktion unterbindet. Allerdings waren die Details des zugrundeliegenden 
Mechanismus nicht bekannt. In dieser Doktorarbeit habe ich die Grundlagen der C2-
vermittelten Autoinhibition zweier Mitglieder der Nedd4-Familie, Smurf2 und Nedd4, 
untersucht. Mit Hilfe von NMR-Spektroskopie und biochemischen Untersuchungen habe 
ich herausgefunden, dass die Bindung der C2- an die HECT-Domäne die E2-E3-
Transthiolierung verhindert indem sie das Enzym in einer katalytisch inaktiven 
Konformation fest hält. Ferner verhindert die C2-Bindung die nicht-kovalente Interaktion 
der HECT-Domäne mit Ub, die einen wichtigen Schritt in der Verlängerung von Ub-Ketten 
darstellt. 
Die Smurf1 E3-Ligase ist ein E3-Enzym, das mehr als 70 % Sequenzidentität mit Smurf2 
aufweist. Allerdings war bis heute unbekannt, ob Smurf1 über denselben C2:HECT 
Autoinhibitionsmechanismus wie Smurf2 verfügt. Meine Studien haben aufgezeigt, dass 
das Smurf1 Volllängeenzym konstitutiv aktiv ist obwohl die C2:HECT Bindungsoberfläche 





Aktivität in trans inhibiert. Ich konnte zeigen, dass dieser gravierende Unterschied 
zwischen Smurf1 und Smurf2 auf die Abwesenheit der WW1 Domäne in Smurf1 zurück zu 
führen ist, die die Bindeaffinität zwischen C2- und HECT-Domäne erhöht.  
Darüber hinaus ist die Ca2+-abhängige Freisetzung der C2-Domäne ein 
Aktivierungsmechanismus für Nedd4-E3-Ligasen. Ich konnte zeigen, dass Calcium an die 
C2-Domäne von Nedd4 mittels einer konservierten Calciumbindedomäne bindet und so 
mit der Interaktion zwischen C2- und HECT-Domäne konkurierrt. Allerdings konnte ich 
auch nachweisen, dass andere Mitglieder der Nedd4-Familie, wie zum Beispiel Smurf1, 
Smurf2 und das Hefehomolog Rsp5 nicht in der Lage sind mit Calcium zu interagieren. 
Diese Ergebnisse deuten darauf hin, dass der Aktivierungsmechanismus über die Ca2+-
abhängige Freisetzung der C2-Domäne von der HECT-Domäne wahrscheinlich auf eine 
kleine Untergruppe der Nedd4-Proteine beschränkt ist.  
Global betrachtet spielen die Enzyme der Nedd4-Familie eine Schlüsselrolle bei der 
Etablierung und Regulation von entwicklungsbiologischen und krebsassoziierten 
Prozessen. Daher sind intensive Studien des Katalysemechanismus und eine detaillierte 
Analyse der proteinspezifischen Regulation dieser Enzyme so wie sie hier in dieser Studie 
vorgestellt werden ein integraler Bestandteil zum Verständnis der HECT-Ligasen und 























1D    One Dimensional 
2D    Two Dimensional 
3D    Three Dimensional 
Ala (A)   Alanine 
Arg (R)  Arginine 
Asn (N)  Asparagine 
Asp (D)  Aspartic acid 
ATP   Adenosine triphosphate 
CBR   Calcium binding region 
CDS   Coding sequence 
C-lobe   C-terminal lobe 
CSP    Chemical shift perturbation 
C-t    Carboxyl terminus 
Cys (C)  Cysteine 
DNA   Deoxyribonucleic acid 
dNTPs   Deoxynucleotides 
DTT    Dithiothreitol 
ECL   Enchanced chemiluminescence 
EGTA       Ethylene glycol tetraacetic acid 
ER    Endoplasmic reticulum 
FD    Fast digest 
FID    Free induction decay 
FT    Fourier transformation 
FL    Full length  
Fw    Forward (primer) 
GAT   GGA and Tom1 domain 
Glu (E)   Glutamic acid 
Gln (Q)  Glutamine  
Gly (G)   Glycine 
h    Hour (s) 
HA    Hemagglutinin 
His (H)   Histidine 
HMQC  Heteronuclear multiple quantum coherence 
HSQC   Heteronuclear single quantum coherence 
Hz    Hetrz 
IM  Isolucine/Methionine 
IMAC   Immobilised metal affinity chromatography 
IP3  Inositol trisphosphate 
IPTG   Isopropyl-d-1-thiogalactopyranoside 
Ile (I)  Isoleucine 





Kd  Dissociation constant 
Koff  Dissociation rate  
Kon  Association rate 
L  Ligand 
LB   Luria Broth 
Leu (L)  Leucine 
Lys (K)  Lysine 
Met (M) Methionine 
mM   Milimolar 
min   Minute (s) 
ms    Milisecond 
μM    Micromolar 
μs    Microsecond 
nM    Nanomolar 
NMR    Nuclear magnetic resonance 
N-lobe N-terminal lobe 
N-t    Amino terminus 
OD    Optical density 
P    Protein 
PAGE   Polyacrylamide gel electrophoresis 
PCR    Polymerase chain reaction 
PD10  Protein desalting column 
Phe (F) Phenylalanine 
Pro (P)  Proline 
PTM   Post-translational modification (s) 
PVDF  Polyvinylidene fluoride 
q.s.  Sufficient quantity 
RE    Restriction enzime 
RF    Radio frequency 
Rv    Reverse (primer) 
ROI   Region of interest (s) 
SAP   Shrimp alkaline phosphatase 
SDS-PAGE  Sodium dodecysulfate- polyacrylamide gel electrophoresis 
SEC    Size-exclusion chromatography 
Ser (S)   Serine 
SI(ngle)  Single HECT 
TBS   Tris-buffered saline 
Thr (T)   Threonine 
Tris    Tris(hydroxymethyl)aminomethane 
TROSY   Transverse relaxation optimized spectroscopy 
Trp (W)  Tryptophan 





UBS    Ubiquitin binding surface 
UPS   Ubiquitin-Proteasome system 
Val (V)   Valine 
WT   Wild type  
 
Name of Domains and Proteins 
 
A20   Ataxin3 
AREL1   Apoptosis-resistant E3 ubiquitin protein ligase 1 
BH3   Bcl-2 (B-cell lymphoma 2) homology 3 
BMP   Bone morphogenetic proteins 
Bsd2    Metal homeostatis protein BSD2 
CUE   Coupling of ubiquitin to ER degradation 
DUBs    Deubiquitylating enzymes   
Dvl2   Dishevelled segment polarity protein 2 
E1    Ubiquitin-activating enzyme 
E2    Ubiquitin-conjugating enzyme 
E3    Ubiquitin ligase 
E6AP   E6-associated protein 
EGFR  Epidermal growth factor receptor 
Hh  Hedgehog 
HACE1 HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1 
hHARI    Human homolog of ariadne  
hHR23   Human homologues of the Rad23 proteins 
HECT    Homologous to the E6-AP C terminus  
HECW1     HECT, C2 and WW domain-containing protein 1 
HECW2  HECT, C2 and WW domain-containing protein 1 
HERC   HECT and RDL containing protein  
HOIP  HOIL-1L interacting protein 
HOIL-1L Heme-oxidized IRP2 ubiquitin ligase 1 
HRP  Horseradish peroxidase 
HUWE1 HECT, UBA and WWE domain-containing protein 1 
IBR  In between RINGs 
Itch  E3 ubiquitin-protein ligase Itchy homolog 
LMP-1  LIM mineralization protein-1 
LUBAC Linear ubiquitin chain assembly complex 
MBP  Maltose-binding protein 
MIU  Motif interacting with ubiquitin 
NEMO  NF-kappa-B essential modulator 
NDFIP1  Nedd4 family-interacting proteins 1 
NDFIP2  Nedd4 family-interacting proteins 1 





Nedd4L   Nedd4-Like 
NF-κB  Nuclear factor kappa-light-chain-enhancer of activated B cells 
Notch   Neurogenic locus notch homolog protein 
NZF   Nlp4 Zinger Fing 
NusA   Transcription termination/antitermination protein (N utilization substance A) 
Parkin    Parkinson juvenile disease protein 2 
PKC   Protein kinase C 
cPLA2   Calcium-dependent phospholipase A2 
PLCs   Phospholipase C 
RAD18   E3 ubiquitin-protein ligase RAD18 
Rap80   Receptor-associated protein 80 
RBR    RING between RINGs 
RDL   RCC1 (Regulator of chromosome condensation 1) like domain 
RING    Really interesting new genes (s) 
Rsp5    Reverses SPT-phenotype protein 5 
SSQ   Heat shock protein SSQ1, mitochondrial 
SHARPIN   SHANK (SH3 and multiple ankyrin repeat domains 3) associated RH domain 
interactor 
Smad7   Mothers against decapentaplegic homolog 7 
Smurf1  Smad ubiquitin regulatory factor 1 
Smurf2  Smad ubiquitin regulatory factor 2 
SPRY  SPla and the RYanodine receptor 
SUMO   Small ubiquitin-like modifier 
TAB2   TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 
TEV    Tobacco etch virus 
TGF-β   Tumor grow factor β 
TNFα  Tumor necrosis factor α 
TRIP12 E3 ubiquitin protein ligase TRIP12 
UIM   Ubiquitin-interacting motif 
USP   Ubiquitin specific protease 
Ub       Ubiquitin 
UBA   Ubiquitin-associated  
Uba   Acceptor ubiquitin 
UBAN   Ubiquitin binding in ABIN and NEMO domain 
Ubd   Donor ubiquitin 
UBD   Ubiquitin binding domain 
UBE3C   Ubiquitin protein ligase E3C 
UBM  Ubiquitin binding motif 
UBL     Ubiquitin-like  
UBP   Ubiquitin binding proteins 
UBR5   E3 ubiquitin protein ligase UBR5 





UEV  Ubiquitin E2 variant 
VHS  Vps27, Hrs, and STAM 
Wnt  Wingless-related integration site 
WWP1  WW Domain containing E3 ubiquitin protein ligase 1 
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the activation of the transcription factor NF-κB. In the case of Lys11-linked chains, it has 
been established that they act as additional proteasomal degradation signal, used 
specifically in cell cycle regulation. Interestingly, M1- and K11-linked chains seem to be 
counterparts to the canonical ones; while both M1- and K63-linked conjugates arrange 
the assembly of protein complexes, K11- and K48-linked chains can drive proteasomal 
degradation. The other four types (Lys6, Lys27, Lys29 and Lys33) are even less studied and 
little information is available (Yau & Rape, 2016). Lys6 and Lys27 seem to be associated 
with DNA repair events, Parkin-mediated mitophagy and immune response. Lys29 is an 
inhibitor of the Wnt signaling pathway, while Lys33 has been implicated in post-Golgi 
protein trafficking (Akutsu et al., 2016) (Table 1). 
Table 1. Biological function of an ubiquitinated protein according to the Ub-chain linkage.  
UBD: Ubiquitin binding domain. The name of a representative protein that contains the 
mentioned domain is shown in brackets.  -: no information available. * The name of 
domains and proteins are described in the “List of abbreviations” section. 
 
Linkage Type Signaling outcome UBD (*) 
mono-Ub Membrane trafficking; endocytosis; viral budding 
UBA, UIM, NZF 
CUE, MIU, VHS, 
GAT, UBZ, UBC, 
UEV, UBM 
Lys6 DNA damage response; Parkin-mediated mitophagy - 
Lys11 Poly-ub chains: human cell cycle control/hypoxia - 
 Branched-chains: strong proteolytic degradation signal - 
Lys27  Nuclear translocation; DNA damage response - 
Lys29 Wtn/b-catenin signaling - 
Lys33 Post-golgi protein traffiking - 









Met-1 Inflammatory and immunity response; NF-kb signaling UBAN (NEMO) 
 
From a structural point of view it is possible to distinguish two conformations that the 
different types of chains can adopt. One is a compact conformation, in which each Ub 
moiety interacts with the next one in the chain (Lys6, Lys11, Lys33 and Lys48-linked). The 
other is an open conformation, where no binding surface between Ub is present, apart 
from the linkage site (Lys 29, Lys63 and Met1-linked chains) (Akutsu et al., 2016; 
Komander & Rape, 2012). 




In addition to homotypic (one linkage type), heterotypic chains can also be formed (Figure 
2). In this case, chains that were linked using one type of linkage are extended by a second 
type. Another option instead, is that the Ub molecule already attached is ubiquitinated at a 
different Lys residue, forming a so-called branched structure. Branching allows E3 ligases 
to increase the local Ub concentration explaining the strong proteolytic signal of branched 
chains (Yau & Rape, 2016). Detailed studies demonstrate that while homotypic Lys11-
chains do not bind to the proteasome, heterotypic Lys11/Lys48-polyubiquitin chains 
induce potent degradation signals (Grice & Nathan, 2016). Early studies in the field defined 
the Lys48-linked tetra-ubiquitin as the canonical signal to trigger degradation (Thrower et 
al., 2000). However, new data suggest that chain branching could convert any non-
degradative chain into a degradation signal. In fact, a “ubiquitination threshold” model has 
been proposed, in which instead of having a specific type of chain, the amount of poly-
ubiquitin is a relevant factor to determine degradation (Swatek & Komander, 2016). 
A second layer of complexity can be added to the system in the case that Ub is modified 
with other PTMs, for instance an UBL (Ubiquitin Like) modifier such as SUMO 
(Sriramachandran & Dohmen, 2014), or when small chemical modifications such as 
phosphorylation or acetylation are introduced (Ohtake et al., 2015; Wauer et al., 2015). All 
Ub moieties, even in complex topologies, could undergo these modifications generating 
an essentially unlimited number of combinations. Following Ub conjugation, the cell needs 
to reliably read and interpret each type of poly-ubiquitin chain and act in consequence. In 
order to do so, the immediate decoders are the Ub receptors, Ub binding proteins (UBPs) 
that contain one or several Ub binding domains (UBDs) (Grabbe et al., 2011) (Table 1). At 
least 20 different families of UBDs (e.g. UBA, UIM, NZF and CUE) present in hundreds of 
human proteins have been described and they often occur in tandem repeats. The 
majority of them recognize the canonical Ub hydrophobic patch centered on Ile44, 
although a small number can interact with other surfaces such as the Ile36 patch, the Phe4 
patch, the Asp58 patch, the TEK box or a flexible loop (Kulathu & Komander, 2012). By 
recognizing a particular Ub surface, UBPs couple substrate ubiquitination to a downstream 
event. However, the mechanism underlying the recognition of each specific linkage is not 
fully understood. The vast majority of UBPs interact with mono-ubiquitinated proteins, with 
affinities in the μM range. The challenge gets tougher when they need to identify distinct 
poly-ubiquitin chains. One way to distinguish among chains is using the existing difference 
in distance between the Ub molecules in each chain type. Many proteins possess multiple 
UIMs domains with a defined spacer between them in order to do that. Another 
mechanism is to differentiate chain flexibility. NZF domains can differentiate Lys63- from 
Met1-linked chains despite their structural similarities; Lys63-linked chains can bend 
allowing a perpendicular way of interaction with the same NZF domain that is not possible 
for Met1-linked Ub chains. Additionally, the context of the linkage (e.g. the sequence in 




the vicinity) as well as a combination of different patches in the molecules of the same 
chain can also be used for specific recognition. Finally, in the last couple of years new 
studies have supported the idea of “induced fit selection”, where the binding of each UBD 
type would be able to change/select a particular Ub conformation (Husnjak & Dikic, 2012; 
Komander & Rape, 2012).  
To prevent ubiquitination from being constitutively active, modifications can be reversed 
by a specific group of Cys proteases called Deubiquitinating enzymes (DUBs), which can 
cleave Ub isopeptide bond at the end or within the chain. Some are in charge of 
protecting Ub from being degraded, which is essential in order to maintain sufficient levels 
of free Ub inside the cell. Others disassemble chains independently of the linkage, but are 
rather substrate specific, such as Ubiquitin specific protease (USPs). On the other hand, 
several DUBs show specificity towards one linkage type. Finally, it is often observed that 
DUBs and E3s coordinate their “writing and erasing” functions by binding to each other 
(Heride et al., 2014).  
1.3 Cellular roles of Ubiquitination  
Clearly, the main task of the ubiquitination pathway is the proteasomal degradation. The 
elimination of unwanted proteins occurs via the conserved Ubiquitin-Proteasome system 
(UPS), where the ubiquitination enzymes are key players, since the fate of ubiquitinated 
substrates depends both on the length and the type of chain linkages. Another key player 
is the 26S proteasome, who consists of two main regions: the proteolytic 20S chamber 
and the 19S regulatory particle. After ubiquitination, the modified protein can be target to 
the proteasome. This can be done directly by the 19S regulatory particle subunits or 
otherwise it can be mediated by proteasomal shuttle factors. These proteins contribute 
with the recognition and transport of ubiquitinated targets which need to reach the 
proteasome from distant locations. They function is critical, since they prevent chain 
disassembly during the transfer, preserving the original signal. When proteins destined for 
degradation reached the entrance of the proteasome, de-ubiquitination takes place. As a 
result, the Ub molecule is recycled and the protein unfolded and translocated to the 
proteolytic chamber for its destruction (Grabbe et al., 2011; Grice & Nathan, 2016). On the 
other hand, mono-ubiquitination or Lys63- as well as Met1- linked chains results in the 
formation of non-proteolytic signals that are involved in roles such as: recruiting proteins 
to participate in particular signaling pathways, attract trafficking factors that change 
substrate localization, or to control substrate activity.  
The way different E3s target substrates varies significantly. Initial studies have revealed that 
many E3 ligases use short linear sequences called degrons to localize their substrates. 
Degrons normally adopt extended conformations to facilitate the interaction. Moreover, 
PTMs of these sequences play a role in recognition. In addition, specific amino acids, 
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located in proximity of the RING. The RING E3 binds then both the E2 and the Ub 
molecule, which is still bound to the E2 through the thioester bond. This holds the C-t tail 
of Ub in a favorable conformation for catalysis. Basically, RING E3s work as scaffold 
proteins that facilitate the ubiquitination reaction by bringing together the E2~Ub and the 
substrate. For RING E3s, the outcome of the reaction is defined mainly by the E2 that 
participates in each particular reaction, whereas which Lys is accessible for modification is 
defined by the E3 (Berndsen & Wolberger, 2014, Buetow & Huang, 2016). 
1.4.1.2 HECT E3 ligases	
From the approximately 600 human E3s, only 28 belong to the HECT class. They are 
named after the conserved C-t of the E6AP HECT domain, the founding member of this 
E3 class. Based on the N-t region HECT E3s can be further divided into 3 groups: the 
Nedd4 family, the HERC family and other HECT or SI(ngle)-HECT E3s (Rotin & Kumar, 
2009). HECT E3s catalyze two distinct reactions: the transference of an Ub molecule from 
the E2 active site to the catalytic Cys located in the HECT domain, forming a thioester 
intermediate, in a so-called transthiolation reaction. Subsequently, the HECT~Ub thioester 
is transferred to a Lys residue in the substrate forming an isopeptide bond. Of note, this 
Lys can also be located in the HECT domain, leading to auto-ubiquitination (Berndsen & 
Wolberger, 2014). 
1.4.1.3 RBR-domain E3 ligases 
To date, this group consists of 14 proteins in humans, from which PARKIN, HHARI and 
HOIP are the most studied. The mechanism they use to perform Ub ligation is different 
from the previous two classes, although it shares features with both of them. From a 
structural point of view, RBRs possess two RING domains (RING1 and RING2) linked by a 
conserved sequence called in between RINGs (IBR). The RING1 domain works similarly to a 
canonical RING domain, recruiting the E2~Ub. On the contrary, the RING2 domain 
resembles a HECT domain, since it bears a catalytic Cys able to form a thioester 
intermediate. Although the general mechanism is similar to HECT E3s, RBR substrate 
ubiquitination seems to be catalyzed differently. The best example is provided by the 
LUBAC complex, which is able to generate peptide-bond formation between the C-t of 
the donor Ub molecule and the Met1 of the acceptor one, generating linear Ub chains 
(Berndsen & Wolberger, 2014; Buetow & Huang, 2016).  
1.4.2 The HECT family in detail 



































































n both of t





















































































 that the p
ge distance
bable that 





 5C). It is p








































hD Thesis – Na











































 to the 
















































 the E2 (B)









ter. In this 
. The transt
-lobe (C) 












 Ub C-t a
. A new ub







 is freed. N














t to a spec
lays an im
trate in clo
hD Thesis – Na
ly (A) unti
lacing the 
 forms a t
lobe rotate
e (D), to p
 of the tar
 occur (F-I











); a new 
he Uba, 
le in Ub 
y to the 




In Nedd4, apart from the catalytic Cys (C867), a highly conserved Asp (D900) and a His 
located near the catalytic Cys (H865) are essential for substrate ubiquitination but not for 
transthiolation, helping in the positioning of the acceptor Ub (Uba) (Maspero et al., 2013). 
Previous reports also showed that a Phe at position -4 is needed for isopeptide formation 
(Salvat et al., 2004). In agreement with this, the Rsp5-Ub-substrate structure published by 
Kamadurai et al., 2013, clarified its function. The “-4 Phe” sits in an N-lobe pocket and 
mediates the inter-lobe contacts anchoring them in an orientation suitable for substrate 
ubiquitination. Of note, in this conformation the C-lobe of Rsp5 is rotated 130°C about the 
hinge loop in comparison with the Nedd4-Ubd structure. This -4 Phe, conserved in all 
HECT E3s, has a clear role in substrate ubiquitination and poly-ubiquitin chain formation, 
but it is not required for the formation of the HECT~Ub intermediate. Moreover, the 
conservation of the N-lobe pocket among the Nedd4 proteins, suggests that the N- and 
C-lobe orientation required for Ub transfer is carried out by a similar mechanism in the 
entire subfamily (Buetow & Huang, 2016).  
Additionally, the majority of the Nedd4 family members interact non-covalently with Ub 
through a surface called ubiquitin-binding site (UBS), which is located on the N-lobe of the 
HECT domain. The UBS is known to be essential for poly-ubiquitin chain elongation, but its 
mutation shows no effect on E2-E3 transthiolation or mono-ubiquitination. Since this UBS 
is remote from the thioester Ub in all available HECT structures, it probably cannot act as 
an Uba in Ub chain elongation, but rather serves as a site for binding ubiquitin-modified 
substrates, promoting processivity (Kamadurai et al., 2013; Maspero et al., 2011; Maspero 
et al., 2013; Ogunjimi et al., 2010). When Ub is ready for catalysis, the E3 ligase positions a 
substrate Lys next to the HECT~Ub thioester for ligation (Figure 5D). If the substrate is 
released, then the reaction results in mono-ubiquitination (Figure 5E). Instead, more Ub 
molecules can be attached to the first one, leading to poly-ubiquitination. This reaction 
can be divided in two stages: the initial transference of Ub to a substrate Lys called 
initiation, and the following rounds, where the Ubd is attached to a Lys on the first Uba, 
called elongation (Figure 5F-I). Basically, the process of poly-Ub chain formation consists 
of a HECT E3 enzyme which faces an E2 to receive the Ub, after what turns around to pass 
it to the substrate. This sequential Ub addition mechanism is used by Nedd4-family E3s 
(Kim & Huibregtse, 2009), while preliminary results suggest that this may not be the case 
for the rest of HECT enzymes (Fajner et al., 2017). How the following Ubs are attached to 
the substrate it is still unknown. One possibility is that when the second Ub is already 
attached to the substrate (Figure 5J), the C-lobe does not need to rotate anymore (Figure 
5K) since the UBS present in the N-lobe would help to maintain the growing Ub chain in 
proximity as well as to position the Uba in the appropriate orientation to elongate the 
chain (Figure 5L). This idea is supported by the fact that the UBS is essential for poly-
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Nedd4 E3s present overlapping but distinct repertoires of substrates, and it seems that the 
specificity is determined by the difference in ligand affinity displayed by the WW domains. 
Even more, as they are present in tandem repeats, they can co-operate to fine-tuned 
WW-ligand interactions (Zou et al., 2015). Finally, the HECT domain, that consist of ~350 
amino acids, which main feature is the ability to form an HECT~Ub thioester intermediate. 
By modulating the stability, localization and function of key players in diverse cellular 
pathways including TGF-β, TNFα, WNT, Notch, EGFR, p53/p73/p63, Hippo and Hh 
signaling, Nedd4 proteins define a multitude of essential cellular phenomena. They 
participate in endocytosis and trafficking of membrane proteins through mono-
ubiquitination. In addition, they build poly-Ub chains mainly through K63 linkages, playing 
a role in the stability of transmembrane receptors as well as intracellular substrates. It has 
also been shown that they can play opposing roles as tumor promoting or suppressing 
factors according to different cellular contexts (Bernassola et al., 2008, Zou et al., 2015).  
Nedd4 is the first member of the family to be described and it is named after the product 
of the neural precursor cell-expressed developmentally downregulated gene 4. It is 
localized in the cytoplasm and is expressed in most tissues. Nedd4 is involved in the 
regulation of cellular homeostasis by down-regulating the activity of epithelial Na+ channel 
(ENaC) and other ion channels found in the brain, thereby affecting fundamental 
processes such as embryonic development and animal growth (Boase & Kumar, 2015).  
There are two Smurf (Smad Ubiquitin Regulatory Factors) proteins in mammalian cells, 
called Smurf1 and Smurf2. They were originally described as negative regulators of the 
Smad (receptor-regulated mothers against decapentaplegic) proteins. They also down-
regulate TGF-β and BMP signaling pathways, resulting in the degradation of critical players 
within those pathways. They are also involved in osteoblast differentiation, cell motility and 
polarity regulation.   
Smurf1 and Smurf2 seem to have dissimilar molecular functions, despite the fact that they 
display 70% of sequence identity and some redundancy in their substrate repertoire. 
Smurf1 has been frequently associated with apoptosis and cancer metastasis. For Smurf2, 
it was shown that its deletion results in alterations in gene expression, DNA damage 
response, and genomic integrity. On the contrary, it also has a role as a tumor suppressor 
(David et al., 2013). 
1.4.2.3 Other HECT families 
The other two HECT families do not show a conserved domain organization N-t to the 
HECT domain as is the case of the Nedd4 family. The HERC family, which has 6 members 
in humans, is defined by the presence of RLDs domains (Regulator of chromosome 
condensation 1 (RCC1) like domains). The small members (HERC3-6, approx. 100 kDa) 
have only one RLD domain while the large ones (HERC1-2, approx. 500 kDa) contain 




multiples RLDs. In addition, they can bear extra domains such as SPRY and WD40 
domains. RLDs are characterized by seven repeats of approx. 60 amino acids that adopt a 
seven-bladed β-propeller fold. From a functional point of view they work both as a 
guanine nucleotide-exchange factor for small GTPase as well as in the interaction with 
chromatin through histones H2A and H2AB (Fajner et al., 2017). Although they have been 
discovered more than 20 years ago, it is still not clear whether all of them act as real E3 
ligases, and only a few substrates are known (Sánchez-Tena et al., 2016). 
The SI(ngle)-family (13 members in humans) is composed of all the HECT E3s which 
possess neither a WW nor a RLD domain. Some of the most relevant members are E6AP, 
HUWE1, HACE1, TRIP12 and UBR5, all of which play important roles in human physiology 
and in human diseases, such as cancer. Little is known about their structure and catalytic 
mechanism, with few exceptions. E6AP, whose HECT structure was the first to be solved, 
bears no other domain apart from the HECT, and it is able to assemble Lys48 linkages 
exclusively. HUWE1 is an extremely large protein of about 500 kDa, which has many extra 
domains like a UBA and a BH3 domain. Its HECT domain structure is also solved, and mass 
spectrometry analysis shows that it assembles K11 linkages (37%), K48 linkages (33%) and 
K6 linkages (26%) (Michel et al., 2017). Since this family includes diverse E3 proteins, each 
of them fulfill different roles through several types of Ub-chains: UBE3C was implicated in 
the assembly of Lys29 linkages and Lys48 linkages; UBR5 was suggested to ubiquitinate 
β-catenin with Lys29- or Lys11-linked ubiquitin chains; AREL1 produces K33 linkages as 
well as K11 and the ankryin repeat containing E3 HACE1 assemble Lys27-linked chains 
(Swatek and Komander, 2016; Yau and Rape, 2016). Importantly, the majority of the 
analysis used to determine linkage types are done in vitro and in the absence of bona fide 
substrates. It has to be taken into account that the presence of natural substrates might 
change the preference that the HECT enzymes show regarding linkage assembly 
(Kristariyanto et al., 2015).  
1.4.3 E3 Activity regulation 
Due to the large amount of processes in which it is involved and the numerous substrates 
it can modify, ubiquitination is considered nowadays of utmost importance (Zou et al., 
2015). Relying on the proteasome/lysosome system it can virtually modulate every process 
in the cell, having also the ability of shutting down complete signal transduction networks. 
E3s define the specificity of the reaction by selecting the substrates that need to be 
modified. Due to these reasons, it is vital for the cell to regulate the activity of these 
enzymes, and different ways have been described how this is achieved in the cell.  
Current evidence indicates that within the cell many E3s are kept in an inhibited state, 
which is mainly achieved by intramolecular interactions that restrict protein flexibility, 
impairing essential processes such as E2~Ub thioester recruitment (Buetow & Huang, 
2016). This is particularly true for the Nedd4 family of HECT E3s (Fajner et al., 2017). 




Interestingly, they have evolved slightly different mechanisms to carry out activation/ 
inactivation, despite that they all exhibited the same domain architecture. The details of 
auto-inhibition were first shown for Smurf2; the enzyme´s inhibition is mediated through 
an C2:HECT domain intramolecular interaction which takes place near the catalytic Cys, 
interfering with Ub thioester formation (Wiesner et al., 2007). Nowadays it is know that 
other members of Nedd4 are also kept in an auto-inhibited conformation (Chen et al., 
2017; Courivaud et al., 2015; Mari*, Ruetalo* et al., 2014; Mund and Pelham, 2009; Wang 
et al. 2010; Wiesner et al., 2007; Zhu et al., 2017), while for Smurf1 there is still 
contradictory data regarding whether it is regulated by auto-inhibition or not (see 4.2.2). 
Subsequently, a mechanism that enables activation must take place. Smurf2 is activated by 
binding of the adaptor protein Smad7 to the WW domains, which releases the auto-
inhibitory state (Ogunjimi et al., 2005), promoting Ub transfer activity. A different way of 
controlling E3 activity is phosphorylation, as is the case of Itch. Both Nedd4 as well as 
Nedd4L, are activated by Ca2+ binding to the C2 domain (Escobedo et al., 2014; Wang et 
al., 2010), which disrupts the interaction between the HECT and the C2 and target the 
protein to the plasma membrane (see 4.3.2). 
E3 regulation involves a great variety of mechanisms that are not mutually-exclusive, since 
one ligase can be regulated by many of them. Those include other PTMs, such as the 
related Neddylation pathway but also other proteins, small molecules and non-protein 
ligands can serve as non-covalent regulators. 
Considering the relevance of E3 ligases not only in physiological but also in pathological 
events, it is indispensable to reveal the molecular mechanisms by which they regulate their 
activity, including possible roles that other proteins or even small modifications can 
provide, in order to understand better the basis of diseases and search for promising 
treatments (Vittal et al., 2015).  
NMR spectroscopy 
2.1 Brief summary of NMR principles  
Nuclear magnetic resonance (NMR) is a spectroscopic technique which takes advantage of 
the magnetic properties of particular nuclei to obtain detailed information about the 
structure and dynamics of molecules. In protein NMR, the most frequently used nuclei are 
1H, 13C and 15N, all of which possess a nuclear spin of ½, meaning that in a static magnetic 
field they have two energy levels, a high and low energy state. In a magnetic field, the 
nuclear spins precess around the direction of the static magnetic field at specific 
frequencies, the so-called Larmor frequency, giving rise to a bulk magnetization that is 
parallel to the direction of the magnetic field. Spin state transitions are achieved and by 
applying energy, i.e. by the absorption of a photon that matches exactly the energy 
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state is mediated by two types of relaxation: the transverse relaxation, due to the loss of 
coherence among nuclei that rotate at their own frequency, and spin-lattice (or 
longitudinal) relaxation due to the transference of energy from spins to the surrounding. 
Both types of relaxation influence the quality of the signal. The slower tumbling of larger 
proteins enhances the FID and gives rise to peak broadening. In this context, the size of 
the protein is a main limitation in NMR experiments, since larger proteins induce faster 
relaxation. However, different approaches are available to slow down the relaxation and 
extend NMR applications to larger proteins. 
2.2 NMR strategies to study large proteins 
There are two major problems associated with the analysis of large proteins by NMR: 
signal overlap and peak broadening. The first arise as a result of the numerous active 
nuclei in the sample, all of which will be observed in a limited spectral range; the spectrum 
gets overcrowded rendering the analysis virtually impossible. The second one is a 
consequence of the relaxation of transverse magnetization. As the size of proteins 
increases, the tumbling rates of biomolecules increase resulting in more abundant spin-
spin interactions which in turn, generates faster relaxation of the NMR signal. Ultimately, 
this translates into spectra of poor sensitivity and resolution. 
To overcome these limitations a number of strategies were developed, including specific 
isotope labeling schemes as well as particular NMR pulse sequences. Deuteration of 
biomolecules is one of the basic approaches (Sattler and Fesik, 1996). Here, the dipole-
dipole interaction can be diminished by replacing protons (1H) with deuterons (2H). Since 
dipolar interactions are proportional to the square of their gyromagnetic ratios and the 
gyromagnetic ratio of 2H is 6.5 times lower than the one of the proton, the benefit of the 
exchange is significant. A second advantage of deuteration, which should also be 
introduced in binding partners and by using heavy water (D2O) as solvent, is the 
suppression of spin diffusion that takes place between protons from the protein and 
protons from the solvent. Heteronuclear experiments done with uniformly labeled proteins 
(15N and 13C isotopes) increase the limit to 25 kDa proteins. Combined with this isotopic 
scheme, deuteration expands the use of NMR up to 50 kDa (Cvetković & Sprangers, 2017). 
The second approach consists of an optimized NMR pulse sequences which helps dealing 
with the slow tumbling of the high molecular weight proteins called transverse relaxation 
optimized spectroscopy (TROSY) (Pervushin et al., 1997), which opened the NMR field to 
study proteins with a molecular weight of up to 100 kDa. The intensity of the NMR signal 
in a particular experiment depends on the amount of initial magnetization as well as on 
the decay rate of this magnetization. While recording a spectrum, several magnetization 
terms are created which decay with different relaxation rates. The TROSY sequence is able 
to separate the coherences that relax slowly (sharp lines) form the ones that relax fast 
(broad lines) and to select only the slowly relaxing ones. As a result spectra of substantially 




improved quality are obtained, in comparison to HSQC experiments, where both fast and 
slow relaxing coherence are merged. Although these two strategies have been extremely 
useful to study large proteins by NMR, it often happens that the negative effects of 
complexity still affect the recording of 1H-15N-based spectra. 
2.3 The Methyl TROSY Experiment 
The combination of 1H,13C-labeled methyl groups in an otherwise fully deuterated protein, 
together with the use of the TROSY pulsing sequence, is currently one of the best 
approaches for studying protein complexes of high molecular weight. This is also true for 
proteins of intermediate size, if the quality of the 1H-15N-TROSY is poor and/or their long-
term stability not enough to assign H-N-bases spectra, as it is the case for the HECT 
domains used in this thesis.  
The advantage of using isotopically labeled-methyl groups comes from their excellent 
relaxation properties which are defined by its three protons arranged symmetrically and 
the fast rotation around its three-fold symmetry axis. This leads to highly sensitive and 
well-resolved NMR signals (Wiesner & Sprangers, 2015). In addition, methyl groups are a 
good choice to study protein interactions. The risk of NMR invisible regions is low since 
methyl groups are evenly distributed in protein structures, being usually located in the 
hydrophobic interior of proteins and along binding surfaces. Also, since they are highly 
sensitive to changes in their chemical environment, subtle events such as side-chain 
rearrangements inside the binding surface will lead to detectable chemical shift changes. 
2.3.1 Labeling Schemes 
An ideal isotopic labeling scheme should consider abundance and distribution of the NMR 
active nuclei in the protein, in order to obtain the data of interest without overcrowding 
the spectra. To perform a methyl-TROSY experiment 1H,13C-labeled methyl groups are 
introduced in particular amino acids, while the rest of the protein should be uniformly 
deuterated. To deuterate the sample, the bacterial culture is grown in D2O-based minimal 
medium with the addition of deuterated glucose. The introduction of 13CH3 labeled groups 
can be done in single residues or in combinations of them, depending on the metabolic 
pathways of each amino acid. In some cases, it is possible to add a methyl labeled 
biosynthetic precursor before overexpression induction. However, if the precursor is 
involved in the metabolic route of another amino acid, this will lead to labeling of more 
than one amino acid type. Several methyl-labeled precursors and/or amino acids are now 
available allowing distinct combinations. In this thesis, the introduction of Ile labeled at 
δ1 position was done by adding the precursor 2-ketobutyrate to the media. On the other 
hand, as the biosynthesis of Val (Valine) and Leu (Leucine) is connected, they methyl 
groups were labeled simultaneously by using 2-keto-3-isovalerate as a precursor. Finally, 
as the pathways of Met and Ala are also involved in the production of other molecules, 




they were added before induction in their final forms Met-ε [13CH3], Ala-β [13CH3] (Kerfah 
et al., 2015).  
2.3.2 Methyl Group Resonance Assignments 
To perform a detailed NMR analysis it is necessary to have assigned spectra, that means, 
knowing which resonance or peak in the spectra belongs to which residue in the protein. 
Traditionally, the collection of data necessary to assign a spectrum, requires to record 
different types of NMR experiments, where the protein has to be highly concentrated and 
stable for a couple of days at the chosen temperature. Usually, this is restricted just to 
small-medium sized proteins.  
In the case of methyl resonances, they can be assigned conventionally with H,N-based 3D 
spectra for proteins up to ~25 kDa proteins. For larger proteins there are two main 
strategies: the “divide and conquer” and the mutagenesis strategy. In the first one, since 
usually small blocks show better spectral quality than the full length (FL) protein, the 
domains are assigned independently and then the individual assignments are transferred 
to the whole spectra. Alternatively, each labeled methyl residue can be individually 
mutated to an NMR-invisible one. In this way, a direct comparison with the wild type (WT) 
spectra will show which peak is the missing residue, allowing its identification (Cvetković & 
Sprangers, 2017).  
2.4 NMR applications 
2.4.1 Protein-protein interaction studies 
NMR spectroscopy is a highly sensitive tool to study biomolecular interactions since the 
resonance frequencies (chemical shifts) of the observed atomic nuclei depend on the local 
chemical environment. Ligand binding causes changes in the local chemical environment 
of those amino acids that are located in the binding pocket resulting in observable 
chemical shift perturbations (CSPs) for those residues. In this regard, NMR is unique since 
it can be used to study strong binding events with nM affinities up to weak interactions 
with dissociation constants in the mM range, providing detailed information about the 
binding surfaces of proteins and complexes in solution.   
CSP mapping is a simple and widely used experimental technique for studying protein 
interactions and identifying binding interfaces (Williamson, 2013). A standard titration 
experiment consists of an isotopically labeled protein and an unlabeled ligand, which can 
be a small molecule or another protein. During the titration experiment the unlabeled 
ligand is added in consecutive steps to the NMR visible protein, modifying the local 
chemical environment of those amino acids that constitute the binding surface. Each 
titration step is followed by the acquisition of a new spectrum. When the interaction under 
study is between two proteins, experiments where each of them is labeled in turns can be 
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constants) for the estimation of the affinity are wanted. A typical set up involves the use 
15N-HSQC spectra since it is the easiest to assign, it is sensitive, and detects only one 
signal per amino acid (with a few exceptions). Nonetheless, 13C-HSQC or HMQC spectra 
can be also used with the advantage that the shifts observed are less influenced by 
structural changes of the protein than for 15N, being better indicators of the effects 
induced upon binding. To study larger proteins, 15N-TROSY spectra are normally weak 
and crowded. A good option then is to use 13CH3 labeling, since methyl side-chains are 
known to be involved in biomolecular interactions and are frequently located in interaction 
binding surfaces. It is possible though, that not enough methyl-containing residues are 
present in the system or region of interest. The “methionine scanning approach” can be 
used to overcome this problem (Stoffregen et al., 2012). Briefly, it involves the introduction 
of methyl-labeled Methionine (Met) instead of solvent exposed residues, one-at-a-time. 
The newly introduced methyl group is easily assigned by comparison of the WT and 
mutant spectra and serves as a reporter for ligand binding. Subsequently, upon ligand 
addition, a new spectrum is recorded. According to the position of the introduced Met 
three different possibilities arise: If the reporter Met is part of the binding interface its 
chemical environment will be affected, producing a CSP. If the reporter is located outside 
the binding pocket, then no correspondent CSP will be observed. Finally, if the residue 
mutated is essential for the interaction (a so-called hotspot) the binding will be disrupted; 
this situation is recognized since not only no CSP for the new resonance will be detected 
but also the naturally occurring methyl groups will display no CSP.     
2.4.2 Chemical shift exchange                              
The dynamic component of proteins has proven to be fundamental for relevant biological 
processes such as enzyme catalysis and allosteric regulation. Indeed, molecular 
recognition inherently involves equilibrium of protein association and dissociation, and is a 
kinetic process that typically occurs in the microsecond to second time scale (Göbl et al., 
2014). The reversible one-site binding of a protein (P) to its ligand (L) is characterized by 
two rate constants (kon and koff) for the association and the dissociation reaction, and the 
dissociation constant (Kd). Kd is an indicator of binding affinity and is equal to koff/kon,   
which in turn equals [P][L]/[PL], where [P], [L] and [PL] are the concentrations of the 
protein, the ligand and the complex formed by P and L. In a CSP experiment, the chemical 
shifts of the free and the bound protein are observed, with the chemical shift 
difference being the difference between these two resonances. The Kd is related to the 
exchange rate between the two states (Kex).  
Depending on Kex of the interaction three different NMR time scales can be defined 
(Figure 9). One possibility is that the complex dissociates very slow, implying that Kex is 
considerably smaller than the difference in chemical shifts between the free and the bound 












































 for PL (Fi
ree protei







if kex >> 
er residue 








































































) to fast ex






































 it is chara
mM to high




y et al., 20
n data can
ystem is su













































a complete analysis of a titration experiment is simplified when the system is in fast 
exchange, since following the signal of a peak from the free to the bound state is usually 
straightforward. In addition, traditional fitting of kinetic constants (such as Kd) using 
equations which depend on P and L concentrations is easily feasible. An accurate estimate 
of the Kd is achieved if many titration curves are fitted simultaneously. Moreover, the 
protein concentration should be close to the 0.5Kd, ranging from Kd/5 to 5Kd. The values 
obtained are reliable from approximately 1 μM up to 10 mM, “which is also close to the 
upper limit for biologically relevant affinities” (Vaynberg and Qin, 2006). Ideally, the 
concentration of the ligand should reach full saturation, but unfortunately this is not 
possible in many cases. 
On the contrary, in the case of slow exchange a re-assignment of chemical shifts in the 
bound state is normally required, since it is impossible to recognize which signal in the 
reference spectra belongs to the signal at the end of the process. By measuring the 
intensity of the peaks that disappear and re-appear the binding constant can be 
calculated, although line broadening makes this process harder. In the intermediate 
exchange, although the peaks shift, the  is less than what is predicted based on the 
simple weighted average. Generally, when the fitted Kd becomes stronger than about 10 
μM the system is leaving the fast exchange.  
An important consideration is that although signal broadening is a typical feature of the 
intermediate/slow exchange regime, it can also happen in fast exchange due to other 
reasons. One is slow tumbling, what happens when the ligand is of high molecular weight 
or if it leads to oligomerization/aggregation. In general, in this case all the signals of the 
labeled protein will broaden and never recover. The other reason could be exchange, 
which can be explained by different factors including that the protein undergoes a pre-
equilibrium conformational change before binding, a structural rearrangement after 
complex formation or protein dimerization before or after binding. In all these cases, even 
considering that the binding of the ligand is fast, broadening is observed. In practical 
terms, when the calculated Kd value is lower than 10 μM and the regime is in fast 
exchange, judging from limited line broadening, the fitted values should be close to the 
true value (Williamson, 2013).  In any case, the level of accuracy in the determination of 
affinities constants can be significantly increased by using lineshape fitting analysis. 
2.4.2 2D line shape fitting 
NMR line shape analysis is a well-established method for the quantitative analysis of 
titration data based upon the fitting of one-dimensional spectra, which can be used to 
study processes on timescales from 10 μs to 100 ms (Rao, 1989).  
The analysis can be extended to two-dimensional experiments, e.g. 15N-HSQC or HMQC 
experiments, for which a couple of additional features had to be taken into account. In the 
first place, each dimension can experience different chemical shift differences and hence 




can be subject to different exchange regimes. A new software called TITAN (Waudby et al., 
2016), able to perform 2D lineshape fitting, has several advantages over the regular 1D 
methods, regarding convenience and accuracy. Performing 2D spectra direct analysis, 
peak overlap is avoided, which is a general problem for biomolecules. The program allows 
selecting ROIs (region of interest) where one or more peaks display CSPs, and doing a 
global fitting, a robust tool for monitoring the quality of each fit. Another major benefit is 
that it tracks the relaxation of magnetization over the entire pulse sequence and performs 
calculations to take that into account. This is especially relevant when the system is in slow-
intermediate exchange regimes, since distinct conformations of the protein caused by 
folding/unfolding reactions, dimerization and other association/dissociation reactions do 
not show the same line width. This can lead to the introduction of errors in the case of 
using 1D analysis methods. Finally, it is essential for a lineshape analysis to obtain reliable 
error values associated with the estimated parameters, for which TITAN performs a 
bootstrap error analysis method based on resampling of fitting residuals in two-











2. Aims and significance of the project 
 
The main aim of this thesis was to contribute to the Ub field by unraveling the mechanisms 
of HECT-mediated ubiquitination and its regulation on a structural and functional level. 
Ubiquitination plays a role in a wide array of biological processes. Therefore, 
understanding how this process is regulated and how E3 ligases carry out their functions 
on a structural level is of great relevance. Moreover, due to their role as central 
determinants of specificity in the ubiquitination process, E3s have emerged as critical 
factors in cancer development and thus are promising targets for drug development 
(Bernassola et al., 2008; David et al., 2013; Zou et al., 2015). 
 
In this thesis, I focused on a particular group of HECT-type E3s: the Nedd4 family. In 
addition to their physiological relevance, they share a conserved domain architecture 
which facilitates a comparative analysis among their members. Using NMR spectroscopy 
and biochemical methods I investigated how the Nedd4-family members Nedd4, Rsp5, 
Smurf1 and Smurf2 regulate their activity. 
 
Some open questions in the field were: 
 How Nedd4-family E3 ligases regulate their activity in order to prevent unwanted 
ubiquitination?  
 Is the already described auto-inhibitory mechanism present and conserved in all 
members of the family? 
 How does the C2 domain mediate this inhibitory role on the HECT domain activity? 
 Are there any conserved mechanisms regarding Nedd4 E3 ligase activation? 
 
As a first step to address these questions, I analyzed in detail how the C2:HECT interaction 
down-regulates the activity of the Nedd4 and Smurf2. I was able to show that the C2 
domain induces a catalytically incompetent HECT domain conformation that interferes 
with the ability of the HECT domain for transthiolation and to interact non-covalently with 
Ub, thereby inhibiting ligase processivity. Altogether, this provides a detailed explanation 
on how Nedd4 E3 ligases can regulate their function. These results are published in: “Mari 
S*, Ruetalo N*, Maspero E, Stoffregen M, Pasqualato S, Polo S, Wiesner S. (2014). 
Structural and Functional Framework for the Autoinhibition of Nedd4-Family Ubiquitin 
Ligases. Structure 22: 1639–1649”. * First author/Equal contribution. 
 
In a second project, I aimed to shed light on the regulation of Smurf1 activity. To this end, 
I performed a detailed structural characterization of Smurf1 intramolecular interactions as 




well as Ub binding, and examined the activity of Smurf1 in comparison with the closely 
related protein Smurf2. Surprisingly, in contrast to Smurf2, Smurf1 is not subject to auto-
inhibition. I could show that this difference in regulation results from the lack of the first 
WW domain in Smurf1. Moreover, I found that the Smurf2 WW1 domain interacts with the 
C2 domain enhancing the interaction and thus auto-inhibition of the HECT domain. In 
sum, these results showed that not all the members of the Nedd4-family undergo the 
same regulatory mechanisms and highlights the relevance of mechanistic studies in single 
proteins, even in highly related ones.  
 
Finally, in a last project, I addressed whether calcium binding is a conserved mechanism of 
activation in Nedd4 family E3s by triggering the release of the C2 domain from the HECT 
domain. I found that Nedd4 C2 domain binds calcium through the conserved CBR and 
that this binding precludes HECT domain interaction, since the binding surfaces use in 
both cases partially overlap. Other members of the family such as Smurf1, Smurf2 and the 
yeast homolog Rsp5 do not bind calcium, restricting Ca2+-mediated C2 releasing as an 




































































































































MGC clone 4781 was obtained from SidNet (Toronto, Canada), UbcH7 from Dr. J.L. Wrana 
(Molecular Genetics, University of Toronto) and Ub from Dr. A.J. Wand (Department of 
Biochemistry & Biophysics, University of Pennsylvania).  
All pETM-derived vectors were obtained from EMBL Heidelberg. pETM-10-60, is a 
modified version of the pETM-60 vector encoding an additional N-t His6-tag.  
All other constructs were generated by PCR from the FL versions of hNedd4, scRsp5, 
hSmurf1 and hSmurf2. 
3.2 Molecular Biology Methods 
3.2.1 Cloning 
3.2.1.1 PCR amplification 
PCR (polymerase chain reactions) were performed according to the manufacturers’ 
protocols using the polymerases Pfu (Promega) for gene amplification and Q5 (New 
England Biolabs) or KapaHiFi (peqlab) for site-directed mutagenesis and RF Cloning. 
Primers were order either from eurofins or SIGMA-ALDRICH. 
3.2.1.2 Site-directed mutagenesis 
Single or multiple point mutations were introduced into the protein CDS using the 
QuikChange strategy (Stratagene). QuikChange primers were designed using PrimerX 
software (Lapid & Gao, 2003). Reactions were carried out according to manufacturers´ 
instructions for the specific polymerase and specific characteristic of each reaction (primer 
melting temperature, vector and insert length, etc.). Typically, a QuikChange reaction 
contained: 50-100 ng of template DNA, 2,5 μL of each Fw and Rv primers (10 μM), 5X 
Buffer, 0,5 μL dNTPS (100 mM), 0,5 μL Polymerase and water q.s. to 50 μL. The PCR 
program included 20 cycles, using annealing temperatures between 50-65°C, according to 
each set of primers.   
After the PCR reaction, the reaction mixture was treated with Fast Digest (FD) DpnI 
restriction enzyme (RE) (Termo Fisher Scientific) which degrades only methylated DNA (in 
this case only the parental DNA is methylated). The product of the reaction was purified 
using the PCR clean-up kit from Macherey-Nagel following the instructions of the 
manufacturer. 5 μL of the final product were transformed into DH5α cells. A negative 
control (PCR without polymerase) was included; it was subjected to DpnI treatment and 
transformed into cells. The absence of colonies in this plate functions as a strong indicator 
that the DpnI reaction was worked successfully.   
3.2.1.3 Restriction Free (RF) cloning 
To deleted or insert large DNA fragments or to clone an entire open reading frame in a 
different vector RF Cloning was used (Unger et al., 2010). Primers were designed with the 




online program available at http://www.rf-cloning.org/. Reactions where set up as 
described in (Ent & Löwe, 2006). Briefly, a first PCR reaction is used to generate a fragment 
called “megaprimer”, which bears the CDS of interest flanked by complementary regions 
to the destination vector. A typical RF PCR reactions contained: 40 ng of vector, 200 ng of 
megaprimer, 5X Buffer, 0,5 μL dNTPS (100 mM), 0,25 μL Polymerase and water q.s. to 25 
μL. The PCR program included ~30 cycles, using annealing temperatures between 60-
65°C.  
The products of the first PCR reaction were analyzed by agarose gel electrophoresis. After 
the final PCR reaction, the product was treated with FD DpnI and purified using the PCR 
clean-up kit from Macherey-Nagel following the instructions of the manufacturer. 5 μL of 
the final product were transform into DH5α cells. A negative control (PCR without 
polymerase) was included; it was subjected to DpnI treatment and transformed into cells. 
The absence of colonies in this plate functions as a strong indicator that the DpnI reaction 
was worked successfully.   
3.2.1.4 Restriction digest and DNA ligation 
Alternatively to RF cloning, traditional restriction enzymes were used when suited better to 
the strategy. FD restriction enzymes (Termo Fisher Scientific) were used to digest both 
vectors and inserts according to the manufacturers’ protocols. Vectors were 
dephosphorylated by adding shrimp alkaline phosphatase (SAP) (New England Biolabs). 
Typically, restriction digest reactions contained: 1 μg DNA, 1μL of each RE, 10X FastDigest 
buffer and water q.s. to 20 μL. 
DNA Ligation was performed using T4 ligase following manufacturer protocols (New 
England Biolabs). A molar ration between insert and vector was calculated to perform the 
reaction in a 1:1 - 1:5 ratio. A negative control (reaction without insert) was always 
included. After incubation 5 μL of the final product was transform into DH5α cells. 
Typically, a ligation reaction contained: 100 ng of vector, from 1-5X molar excess of DNA 
insert, 1 μL T4 DNA ligase, 10×T4 DNA Ligase and water q.s. to 10 μL. 
3.2.2 Plasmid transformation 
Plasmid transformation into chemically or electro-competent E. coli was performed using 
either DH5α cells for plasmid amplification or chemically competent BL21-CodonPlus 
(DE3)-RIL cells for protein expression. 50 μL of competent cells were thawed on ice. In 
case of a PCR reaction 5 μL of PCR product was used, otherwise only 1 μL was used. Cells 
were incubated with DNA on ice for 30 min and subjected to a heat shock for 60 seconds 
at 42°C. Alternatively, they were incubated for 5 min. and electroporated. After the 
procedure, cells were incubated on ice for 2 additional min. Then, 500 μl of LB media was 
added and the cells were recovered at 37°C for another 30 min. (for vectors with 




ampicillin-resistance) or 60 min. (for vectors that were kanamycin-resistant) before plating 
with the appropriate antibiotic. Plates were incubated overnight at 37°C. 
3.2.3 Plasmid isolation and sequencing 
Single colonies from agar plates were used to inoculate 7 mL LB cultures, which were 
grown overnight at 37 °C with the addition of the required antibiotic. Pellets were treated 
for plasmid isolation according to the NucleoSpin Plasmid EasyPure protocol from 
Macherey-Nagel. Elution of the plasmid from the column was performed with 30 μL of 
elution buffer. Plasmids of interest were analyzed by Sanger sequencing. ~80 ng of 
plasmid was added to a sequencing reaction mix that contained: 1 μL of primer, 5x 
sequencing buffer, 0,5 μL of BDT-mix (BigDye™Terminator-mix), and water q.s. to 10 μL. 
Completed reactions were submitted to the in-house sequencing facility for capillarity gel 
electrophoresis and computer analysis. Sequencing results were analyzed with Bioedit 
Sequence Alignment Editor (Hall, 1999). 
3.3 Protein Methods 
3.3.1 Protein Expression and Purification for biochemical assays 
All proteins used in biochemical assays were expressed as His6-fusion proteins using E. coli 
BL21-CodonPlus (DE3) RIL cells (Stratagene) grown in Luria broth (LB) medium. Cultures 
were grown at 37 °C until an OD600 of 0.8 was reached, then the temperature was shifted 
to 18 °C and the cells were induced with 1 mM IPTG and grown overnight (16 h). Cells 
were harvested by centrifugation and lysed by sonication on ice (lysis buffer: 50 mM Tris-
HCl pH 8, 150-300 mM NaCl, 0-5% glycerol, 10-30 mM imidazole, 1 mM DTT 
(Dithiothreitol). Protease inhibitors (Roche) were added for FL proteins. Cell debris was 
removed by centrifugation. Soluble recombinant proteins in the supernatants were 
purified by Immobilized metal affinity chromatography (IMAC). N-terminal solubility tags 
(NusA, MBP, or Z-domain) were cleaved with TEV protease and removed together with 
the His-tagged TEV protease via Ni-affinity and / or size exclusion chromatography (SEC). 
For the FL or chimeric proteins expressed from pETM-11 or pProExHTb vectors, the His-
tag was not removed and after IMAC the buffer was exchange using PD10 columns. In the 
case of HECT domains the His-tag was removed by TEV protease and Ni-affinity when 
used for auto-ubiquitination and competition assays. On the contrary, no His-tag was 
removed for pull-down experiments. The final protein buffer for assays was 50 mM Tris pH 
8.0, 200 mM NaCl, 2.5% glycerol, 1 mM DTT. 
3.3.2 Protein Expression and Purification for NMR Spectroscopy 
All proteins for NMR spectroscopy were expressed in E. coli BL21-CodonPlus (DE3) RIL 
cells (Stratagene). Unlabeled proteins used as titration ligands were grown in LB or in 
90/10% D2O/H2O when the complexes to study exceeded 40 kDa. 15N labeled-proteins 




were expressed in M9 minimal medium (when smaller than 20 kDa), otherwise in 90/10% 
D2O/H2O using 15NH4Cl as sole sources of nitrogen. 13C IM (Met-[ε 13CH3]-, Ile-[δ1 13CH3]- 
or ILVAM- (Ile-[δ1 13CH3]-; Leu-[δ  13CH3]-; Val-[γ  13CH3]-; Ala-[β 13CH3]-; Met-[ε 13CH3]), 
HECT domains were expressed in 90/10% D2O/H2O or 100% D2O M9 minimal medium 
using 14NH4Cl and 12C2H glucose as nitrogen and carbon source respectively. Pre-cultures 
were grown in LB and the amount of bacteria required for inoculation of a culture at an 
OD600=0.4 spun down and re-suspended in the minimal media. Isotopic labeled amino 
acids (L-Methionine-methyl-1H13C, L-Alanine-3-2D13C) or precursors (Ile: 2-Ketobutyric 
acid-4-13C; Val-Leu: 2-Keto-3-methyl-13C-butyric-4-13C acid) were added to the growth 
medium 1 h before induction, which was performed at an OD600=0.8 between 20-25 °C 
with 1mM IPTG. The cells were grown overnight (~ 12-16 h). Cells were harvested by 
centrifugation and lysed by sonication on ice (lysis buffer: 50 mM Tris-HCl pH 8, 150-300 
mM NaCl, 0-5% glycerol, 10-30 mM imidazole, 1 mM DTT). Cell debris was removed by 
centrifugation and purification performed by IMAC. Removal of His-tag and N-t solubility 
tags (NusA, MBP, GST or Z domain) was done by a 2nd IMAC and SEC when required.  
Both, the Nedd4 C2 and HECT domains, were buffer exchanged into NMR buffer (50 mM 
Tris-HCl pH 7.0, 200 mM NaCl, 2.5% glycerol, 1 mM DTT). In the case of Smurf1 and 
Smurf2 experiments the HECT and C2 domains as well as all Smurf2 C2-WW1 and Ub 
were buffer exchanged into NMR buffer (20 mM NaP pH 6.5 or 7.5, 150 mM NaCl, 1 mM 
DTT). Finally, the C2 domains used in Ca2+ binding experiments were exchanged into the 
NMR buffer (20 mM Tris pH=7-7.5, 250 mM NaCl, 1mM EGTA).  
3.3.3 SEC 
When required, proteins where further purified by SEC. According to the protein size 
Superdex 75 (3-70 kDa) or 200 (10-600 kDa) 16/60 columns (GE) were used. The columns 
were used according to the instructions of the manufacturer on either an NGC (Biorad) or 
ÄktaPrime (GE) FPLC system. Fractions were collected in volumes of 0.5-1 mL. Elution 
profiles were monitored by UV absorption at 280nm and the presence and purity of the 
desired protein verified by SDS-PAGE. 
3.3.4 PAGE 
3.3.4.1 Tris-glycine SDS-PAGE 
Relevant fractions after protein purification, level of protein purity as well as protein size 
were analyzed by SDS-PAGE. Gels were casted from a 40%, 29:1 mix of acrylamide: 
bisacrylamide (Sigma) using standard recipes (Laemmli, 1970). Proteins were loaded using 
3X Laemmli buffer on gel with different acrylamide percentages (8, 12 or 16%) according 
to the characteristics of the sample. Electrophoresis was ran at 220 V and gels stained with 
Coomassie brilliant blue G-250. 




3.3.4.2 Tris-tricine SDS-PAGE 
This method is useful for separation of peptides and proteins under 10 to 15 kDa, what is 
usually not possible in the traditional Tris-glycine discontinuous gel system, due to the co-
migration of SDS and small proteins. In order to obtain better results for Ub analysis, 11% 
Tris-tricine (Schägger, 2006) gels were used. 
3.3.5 Western blot 
Antibodies and their suppliers were: α-mouse mono-Ub (P4D1; Santa Cruz 
Biotechnology); α-mouse mono-HA (Sigma), and α-HRP-coupled mouse IgG secondary 
antibody (ThermoScientific).  
Desired amounts of proteins were loaded onto SDS-PAGE or Tricine-SDS-PAGE for 
electrophoresis. Proteins were transferred to nitrocellulose (Santacruz Biotechnology) in 
the case of pull-down experiments or polyvinylidene fluoride (PVDF) membranes 
(Immobilion P, Millipore) for auto-ubiquitination assays in western blot transfer tanks 
(Hoefer system) that contained transfer buffer (250 mM Tris, pH 8.3, 192 mM Glycine, 20% 
v/v ethanol). PVDF membranes were previously activated by incubation in 100% MetOH 
for 1 min. at room temperature. Protein transfer was achieved at 50V for 1.5 hs or 20V 
overnight. For nitrocellulose membranes, Ponceau staining was carried out after protein 
transfer. Membranes were blocked for 1 h (or overnight) in 5% milk in Tris-buffered saline 
(TBS) supplemented with 0.05% Tween (TBS-T). After blocking, they were incubated with 
the primary antibody (α-Ub 1:1000; α-HA 1:5000) diluted in TBS-T 2.5% milk for 1.5 hs at 
room temperature, followed by three washes of 10 min. each in TBS-T. Next, membranes 
were incubated with the appropriate HRP-secondary antibody (α-mouse IgG 1:10000) 
diluted in TBS-T 2,5% milk for 1 h. Finally, membranes were washed three times in TBS-T 
and imaged using the enhanced chemiluminescence (ECL) method (Pierce). Images were 
acquired by using an Amersham Imager 600 (GE). After signal detection membranes were 
stained with InstantBlue (expedeon).  
Western blot quantification was performed using the open source software ImageJ 1.x (by 
Wayne Rasband, 1997; Schneider et al., 2012) following the recommendations for 
densitometric analysis in the ImageJ User Guide IJ 1.46r. 
 
3.4 NMR spectroscopy 
 
All NMR data were collected on an 800 MHz Bruker Avance-III spectrometer, equipped 
with a room temperature probe head. The software used was TOPSPIN 2.1 (Bruker, 2008). 
All NMR data were processed and analyzed using the NMRPipe/NMRDraw program suite 
(Delaglio et al., 1995), and depicted with NMRView (OneMoonScientific). 
 




3.4.1 Nedd4 Interaction studies 
The NMR active sample was a 100 μM partially deuterated 15N-labeled Nedd4 HECT ΔC-t 
domain. 2D 1H,15N-TROSY-based spectra were recorded at 30 °C before and after 
addition of a two-fold stoichiometric excess of unlabeled Nedd4 C2 domain or Ub, 
respectively.  
3.4.2 Smurf1 and Smurf2 HECT CSP experiments  
The NMR active sample was a 50 μM IM or ILVAM-labeled Smurf1 HECT domain and IM-
labeled Smurf2 HECT domain. 2D 1H,13C-methyl-TROSY spectra were recorded at 30 °C, 
before and after addition of unlabeled Smurf1/Smurf2 C2 or Smurf2 C2WW1 domain 
respectively or monomeric Ub. The stoichiometric excess used is indicated in each figure. 
3.4.3 Smurf1 HECT Resonance assignment 
All Ile 1 and Met -methyl groups of the Smurf1 HECT domain were mutated to Val or 
Leu. In total, 29 individual point mutants of the Smurf1 HECT domain were generated: 
I375V, I382L, I390V, M391V, M393V, M403V, M429V, I444V, I449L, M446V, I455V, I469V, 
M470V, I480V, I497V, I516V, I521V, I539V, M571V, I574V, I589V, I605V, I606V, I612V, 
I632V, I683V, I686V, I703V, I705V. 2D 1H,13C -methyl-TROSY spectra of 40 μM IM-labeled 
mutant Smurf1 HECT domains were recorded at 30 °C and compared to the WT 
spectrum. 
3.4.4 Kd determination by two-dimensional lineshape fitting analysis. 
Dissociation constants were calculated from 1H,13C-methyl-TROSY spectra using TITAN 
(Methyl version:cwaudby_titan_95C5769C3906) according to developer´s instructions and 
online documentation (Waudby et al., 2016). Spectra were acquired with 1024 and 120 
points in the 1H and 13C dimensions respectively, and processed with exponential window 
functions with a line broadening of 4 Hz and 8 Hz. Spectra were zero-filled to 4096 and 
480 points in the 1H and 13C dimensions, respectively. Errors were estimated with 
bootstrapping statistics on 100 replicas. Figures for lineshape analyses were prepared with 
TITAN. 
3.4.5 C2 domain CSP experiments 	
The NMR active sample were 100 μM 15N-labeled C2 domains: Nedd4, Smurf1, Smurf2 
and Rsp5. 2D 1H,15N-HSQC spectra were recorded at 25 °C before and after addition of a 
buffered CaCl2 solution (20 mM Tris pH=7, 250 mM NaCl and 1 mM EGTA). For Nedd4 C2 
mutants the same buffer (pH =7 or 7.5) was used. 
Chemical shift perturbations were analyzed with TOPSPIN and quantified as average 
chemical shift changes ΔδAv = ((Δδ(1H))2/5 + (Δδ(15N))2)1/2 in p.p.m. The absolute value 
was plotted against the peak number. 
 




For the Nedd4 HECT domain, 2D 1H,15N-TROSY spectra of an 80 μM 15N-labeled sample 
in the absence and presence of unlabeled C2 domain were recorded at 25 °C. After that, 
an excess of 20 mM CaCl2 was added and a new spectra recorded.  
 
3.5 Structure modeling and visualization 
 
A homology model of the Smurf1 HECT domain were generated using HHPred based on 
the structure of the Smurf2 HECT domain (1ZVD) that shares 86% sequence identity. 
Alignments are made with Jalview (Waterhouse et al., 2009). Prediction of secondary 
structure elements was performed with Quick2D (Alva et al., 2016).  
All structural representations were prepared with PyMOL (The PyMOL Molecular Graphics 
System, Version 1.7.6.6 Schrödinger, LLC). 
 
3.6 Functional assays 
3.6.1 Ubiquitination and Competition Assays 
Auto-ubiquitination assays were performed at room temperature in 25 L reactions using  
ubiquitination buffer (25 mM Tris-HCl pH 7.5, 50 mM NaCl, 0.1 mM DTT, 5 mM MgCl2, 
and 2.5 mM ATP),  and purified enzymes (0.6 M E1, 90 M UbcH7 (E2), 2,5 M E3s) and 
65 M Ub. Reaction mixtures were stopped at specific time points indicated in each figure 
by addition of Laemmli buffer containing 100 mM DTT. For SDS-PAGE analysis, samples 
were loaded on 8-12% acrylamide gels. Detection was performed either by 
immunoblotting with an α-Ub antibody. After signal detection, PVDF membranes were 
stained with Coomassie to show equal loading of proteins. Alternatively, fluorescent 
labeled Ubiquitin was used, kindly provided by Magnus Jäckl. In this case no Western blot 
is needed, since the fluorescent signal of Ub can be directly measured in an Imager.  
Competition assays were performed for Smurf1 and Smurf2 HECT domains. In addition to 
the reaction mix used for the ubiquitination assay, an excess of Smurf1 or Smurf2 C2 
domain or a C2-linker-WW1 fragment (12.5, 25, 50 or 75 M) was added. Samples were 
incubated for 20 min. at room temperature and loaded on 12% acrylamide gels for SDS-
PAGE and immunoblotting. An input gel (in the absence of E1 and E2) was run in each 
case on a 16% acrylamide SDS-PAGE to show the initial amounts of protein. 
3.6.2 Thioester Assays 
Thioester assays were done essentially as previously described (Wiesner et al., 2007). They 
were performed at room temperature in ubiquitination buffer using recombinantly 
expressed and purified enzymes (0.6 M E1, 9 M UbcH7, 4 M Smurf2 proteins) and 13 
M HA-tagged Ub. To better visualize the reduction-sensitive Ub thioester, the Smurf2 
WT, ΔC2 and Y453A enzymes were truncated by four residues from their C termini (‘‘-4’’) 




as deletion of the conserved -4 Phe position impairs HECT-mediated Ub isopeptide-
linkage without affecting thioester formation (Salvat et al., 2004). The reactions were 
divided in two after the indicated incubation times and stopped with SDS-PAGE loading 
buffer without DTT or with 100 mM DTT. Ub-modified proteins were detected by 
immunoblotting with α-HA antibody against HA-tagged Ub, whereas levels of unmodified 
proteins were depicted by Ponceau staining. 
3.7 Pull-Down Assays 
 
Bacterially expressed His6-tagged Smurf2 proteins were incubated at 2 mM with 250 ng 
synthetic K63-linked poly-Ub (Boston Biochem) for 2 hs at 4 °C in YY buffer (50 mM Na-
HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton X-100). 
After four washes with YY buffer, specifically bound proteins were resolved with Tris-
Tricine PAGE (11%) and detected by immunoblotting using α-Ub antibody. Nitrocellulose 
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Figure 10. Chemical shift mapping of the Smurf2 C2 binding surface onto the HECT 
domain. The residues displaying CSPs are highlighted on the crystal structure of Smurf2 
HECT domain (PDB ID: 1ZVD). ‘‘Hot spot’’, ‘‘In’’ and ‘‘Out’’ residues are shown in dark pink, 
light pink and dark gray respectively. Relevant CSPs on naturally occurring methyl groups 
(IMref) are shown in yellow and the catalytic Cys in orange. The Met scanning experiments 
were performed by Mira Stoffregen and Silke Wiesner. This figure is reproduced from 
Mari*, Ruetalo* et al., 2014 with permission from Elsevier. 
 
involved in the interaction (I402, M411, M449, I489 and I626). The individual mutation of 
21 solvent-exposed residues in the region, together with the 1H,13C-Ile-1, Met--methyl 
TROSY spectra assignments (which were previously done by site-directed mutagenesis), 
made it possible to identify the C2 binding surface in detail (Figure 10). The data showed 
that the binding occurs through electrostatic and hydrophobic interactions by residues 
located on the N1 sub-domain of the N-t lobe of the Smurf2 HECT domain. The Ub non-
covalent interaction surface has been shown to be essential in Ub chain elongation for 
Smurf2. Interestingly, the Nedd4 C2 domain binding surface, overlaps substantially with 
this previously mapped interface (Ogunjimi, et al., 2010). In 2012, preliminary results from 
Dr. Simona Polo´s group suggested that same auto-inhibitory mechanism may regulate 
Nedd4 activity. In that context, I aimed to find structural evidence of this mechanism in 
Nedd4 and to study how the C2-HECT interaction mediates the activity inhibition that was 
observed both for Smurf2 as well as for Nedd4. 
4.1.3 Results 
 
Structural analysis of Smurf2 HECT binding surfaces clearly showed a partial overlap 
between the C2 binding surface that our group mapped, and the non-covalent UBS 
previously described by several groups (French et al., 2009; Kim et al., 2011; Maspero et 
al., 2011; Ogunjimi et al., 2010) which is shown in Figure 11A-B.  
Considering that the residues involved in the C2 binding pockets are highly conserved in 
many HECT domains of the Nedd4 family, I studied a possible C2-HECT interaction for 
Nedd4. A methyl-TROSY spectra of a 1H,13C-Ile-1, Met--methyl labeled Nedd4 HECT 
domain was recorded. Unfortunately, the quality of the spectra was not good enough to 
performed titration experiments due to precipitation of the Nedd4 C2 domain at 
concentrations higher than a two-fold excess. Alternatively, I recorded 1H,15N-TROSY NMR 
spectra of a partially deuterated 15N-labeled Nedd4 HECT domain, in the absence and 
presence of a two-fold stoichiometric excess of unlabeled C2 domain. Numerous CSPs 
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Interestingly, the inhibition that the C2 domain exerts on the HECT domain is not fully 
effective. In ubiquitination assays, we consistently observed low levels of FL activity. This is 
probably due to a dynamic interaction between the C2 and the HECT domains, whit “on” 
and “off” states, resulting in basal activity. In the context of E3 ligase function, rather than 
achieving full inactivation of the enzyme, it may be sufficient to avoid the generation of a 
signal that would deplete the ligase itself or off-targets from the cell. In addition, this 
transient nature of the C2-HECT interaction might be beneficial if a fast response from 
these enzymes is needed. A consequence of this transient dissociation would be an 
eventual thioester formation. However, the C2 could still have the possibility to re-
associate, and in this case to outcompete the Ub from the UBS, inhibiting chain formation. 
This then, might be a reason why the C2 domain has the potential to inhibit HECT 
domains at two different steps of the ubiquitination pathway. 
Finally, the observation of a rather large overlapping region between the C2 binding 
surface and the UBS, would suggest that Ub could compete with the C2 domain for the 
HECT domain binding. The Kd values determined for different C2: or Ub:HECT interactions 
might support this hypothesis since they are in the same range (Table 3). However, the 
auto-ubiquitination assays showed that although a large stoichiometric excess of Ub with 
respect to the C2 domain is present in the assays, it is not enough to activate FL Smurf2. 
This fact evidences the strong effect that C2 domain can exert on the HECT domain as a 
























Silke Wiesner performed the titration experiments shown in Figure 22A and the NMR 
experiments to assign the linker-WW1 constructs. She assigned the C2-linker-WW1 region 
spectra shown in Figure 31A. Samira Anders performed the titration experiments shown in 
Figure 29 and Figure 31A. Magnus Jäckl recorded the data shown in Figure 30. The 
backbone resonance assignments of the Smurf1 C2 domain were available in our group, 
performed by Christine Wolf. All other experiments shown in the section 4.2.3 of this thesis 
were performed by me. 
4.2.2 Introduction 
 
Under basal cell conditions (in the absence of substrates or adaptor proteins), the catalytic 
activity of Nedd4-family E3s is down-regulated by intramolecular interactions that prevent 
premature auto- and substrate ubiquitination. In various Nedd4 members, such as Smurf2 
(Mari*, Ruetalo* et al., 2014; Wiesner et al., 2007), Nedd4 (Mari*, Ruetalo* et al., 2014; 
Mund & Pelham, 2009) and Nedd4L (Escobedo et al., 2014; Wang et al., 2010) the N-t C2 
domain interacts with the C-t HECT domain to inhibit ligase activity. This interaction 
precludes E2-E3 transthiolation and blocks the non-covalent UBS that is important for Ub 
chain elongation (Figure 15, 16) (Mari*, Ruetalo* et al., 2014; Wiesner et al., 2007). In the 
case of WWP1 (Courivaud et al., 2015) and WWP2 (Mund et al., 2015; Wiesner et al., 
2007) in vitro ubiquitination assays have shown that it is a combination of C2 and WW 
domains that down-regulates activity. In the case of Itch instead, auto-inhibition does not 
involve the C2 domain, but is mediated by an intramolecular interaction between the two 
central WW domains and the HECT domain (Gallagher et al., 2006; Riling et al., 2015). 
Recently, two crystal structures provided an explanation on how the WW domains of Itch, 
WWP1 and WWP2 maintain their enzymes in the closed conformation. The linker between 
the WW2 and WW3 domains interacts with the HECT domain, impairing E2-E3 
transthiolation (Chen et al., 2017; Zhu et al., 2017). In more detail, Chen et al., 2017 
showed for WWP2 that a 26-residue long α-helix in the WW2-WW3 linker wraps around 
the HECT domain, making extensive contact with both the N and C-lobe (Figure 16). This 
interaction restrains the flexibility of the C-lobe, contributing to enzyme inhibition. In the 
case of Itch, the WW2 domain and the linker connecting the WW2 and WW3 domains 
(WW2L) bind specifically to the HECT domain, restricting its inter-lobe motions (Zhu et al., 
2017). Detailed analysis of the interaction surfaces revealed that the region where the 
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Figure 32. The WW1 domain and the C2-WW1L potentiate the C2-mediated inhibition of 
the Smurf2 HECT domain. In vitro auto-ubiquitination of the Smurf2 HECT domain in the 
absence and presence of a stoichiometric excess of the C2 domain (left panel) and the C2-
linker-WW1 construct (right panel) as indicated. All proteins were bacterially expressed 
and purified. Reactions were prepared using fluorescent-labeled Ub that was used for 
detection. Samples were separated by SDS-PAGE (top panels). Protein levels in the starting 
material were confirmed by Coomassie staining (bottom panels). The inhibition effect 
exerted by the C2 domain on Smurf2 HECT activity is enhanced significantly by the 
presence of the linker-WW1 region. 
 
Consistent with the increased affinity of the C2-linker-WW1 construct for the HECT 
domain (Table 3 vs. Table 4), the auto-ubiquitination signal dropped to almost 
undetectable levels for the C2-linker-WW1 construct already at a five-fold stoichiometric 
excess, while the C2 domain at the same level had only a minor inhibitory effect on HECT 
domain activity. This confirms that the WW1 domain and the C2-WW1L region play an 
important role in mediating Smurf2 auto-inhibition. 
 
Conclusions: 
 The Smurf1 HECT domain interacts with the C2 domain in trans and contains a 
non-covalent UBS that overlaps with the C2 interaction surface. 
 Both surfaces, the C2 binding surface and the UBS, are highly conserved between 
Smurf1 and Smurf2. 
 The Smurf1 C2 domain is capable of inhibiting the HECT domain in trans. None-
the-less, I found that the FL Smurf1 enzyme is not inhibited by a C2:HECT 
interaction. 
 I found that the difference in regulation between Smurf1 and Smurf2 stems from 
the lack of the WW1 domain in Smurf1.	
 Smurf2 WW1 domain interacts in trans neither with the C2 nor with the HECT 
domain. In contrast, addition of the C2-linker-WW1 constructs to the HECT domain 
shows a significantly decrease in HECT activity in comparison with the effect 
exerted by the C2 alone. 
 The C2-WW1L region and the WW1 domain mediate an intramolecular interaction 
with the C2 domain and thereby increase the affinity of the C2 domain for the 
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catalytic HECT domain to inhibit ubiquitination activity (Figure 16A). In others, the linker 
region in between the central WW domains influences ligase activity interacting extensively 
with the N and the C-lobe of the HECT domain, which impairs E2-E3 transthiolation (Chen 
et al., 2017; Zhu et al., 2017) (Figure 16B). I found that the WW1 domain contributes to the 
inhibition of Smurf2 activity. Although it was already known that the Smurf2 C2 domain 
inhibits the HECT activity, I showed in this thesis that the presence of WW1 domain 
significantly enhances this effect. Although the isolated WW1 domain does not interact 
with the HECT or the C2 domain in trans, it enhances the affinity of the C2 domain to the 
HECT domain by a factor of 20 when coupled to the C2 domain (C2-linker-WW1 
construct). An explanation can be given by the fact that the C2 domain interacts with the 
C2-WW1L. This might restrict the WW1 orientation in a way in which is able to help the C2 
domain in its inhibitory role, by increasing C2:HECT domain affinity. This explanation fits 
with my model, since the C2:C2-WW1L intramolecular interaction maps to the bottom 
part of the C2 domain, leaving free the residues involved in HECT binding, located at the 
opposite side of the C2 domain. In addition, the result showed in Figure 29, where 
C2:WW1 do not interact with each other are also in agreement, since the interaction 
detected is mediated by the linker, which is not present in that experiment. 
In contrast, Smurf1 lacks the WW1 domain and as a consequence the C2 domain is not 
able to interact or position itself appropriately to down-regulate HECT activity. Consistent 
with this, recombinant Smurf1 FL is a constitutively active E3 enzyme in vitro. Although 
Smurf1 has been reported in a previous study to be subject to C2-mediated inhibition 
(Wan et al., 2011), my results are fully consistent with at least three other studies that find 
that Smurf1 is not regulated by a C2:HECT interaction (Courivaud et al., 2015; Lu et al., 
2011; Mund et al., 2015).  The fact that Smurf1 is not inhibited by the C2 domain 
emphasizes the role of the WW1 domain, since I showed that the C2 is capable of exert 
inhibition in trans. In any case, it is unknown whether Smurf1 is indeed a constitutively 
active ligase under endogenous expression levels. Since Smurf1 plays important roles in 
key developmental processes, it seems unlikely that Smurf1 activity would not be 
regulated in vivo. Mechanisms of regulation, that may be obscured under in vitro or 
overexpression conditions, would be PTMs of Smurf1 or the presence of adaptor proteins 
that may inhibit Smurf1 activity in cells. Moreover, target-regulated expression or 
differential activity depending on the cellular localization of Smurf1 could also prevent 
premature target ubiquitination. In fact, the substrate specificities of Smurf ligases have 
been linked to both PTMs (Cheng et al., 2011; Narimatsu et al., 2009; Ozdamar et al., 
2005) and cellular localization (Lu et al., 2011). 
Lastly, given the high level of sequence identity between Smurf1 and Smurf2, the fact that 
these enzymes are regulated differently is surprising. This study thus emphasizes the 
importance of detailed mechanistic studies in order to decipher the molecular basis of 




ligase activity. As Nedd4-family members are important regulators of developmental and 
carcinogenic processes, the detailed studies of the catalytic mechanisms and differential 
regulation of these enzymes as presented here, have direct implications not only for 







































Chapter 3: Ca2+ Binding to the C2 domain as an activating mechanism for 
Nedd4 family E3 ligases  
4.3.1 Contribution 
 
Backbone resonance assignments for CSP mapping for the Smurf1 and Rsp5 C2 domains 
were performed by Christine Wolf and Silke Wiesner. Backbone resonance assignments for 
the Smurf2 C2 domain are published (Wiesner et al., 2007). The NMR structure shown in 
Figure 39A was solved by Vincent Truffault. All other experiments described in section 
4.3.3 of this thesis were performed by me. 
4.3.2 Introduction 
 
There is now ample evidence that under basal conditions the majority of Nedd4-family 
ligases are in an inactive state which is mediated by intramolecular interactions (Chen et 
al., 2017; Courivaud et al., 2015; Mari*, Ruetalo* et al., 2014; Mund and Pelham, 2009; 
Wang et al. 2010; Wiesner et al., 2007; Zhu et al., 2017). This C2 or WW2-3L:HECT 
interaction comprises the main way to regulate Nedd4 E3 ligases function, crucial for 
maintaining cell homeostasis (see interaction 4.2.2). On the other hand, in order to 
activate the ligase, a mechanism to disrupt the correspondent interaction must exist. 
Nedd4 E3 ligases have developed different strategies. For Smurf2 it has been described 
that binding to an adaptor protein release the inhibition. Smad7, a bona fide Smurf2 
substrate, binds to the HECT domain of Smurf2, out-competing the C2 domain. In 
addition, Smad7 recruits the proper E2, leading to enzyme activation (Ogunjimi et al., 
2005). Another example of activation by adaptor proteins was described for Nedd4 and 
Itch, mediated by the Nedd4 family-interacting proteins (Ndfip1/Ndfip2). They activate the 
catalysis by binding to the WW domains, but multiple PY–WW interactions are required to 
activate the protein. The binding introduces a conformational constraint that disrupts the 
correspondent intramolecular interaction (C2 domain or WW2-3L region with the HECT 
domain), releasing the HECT domain to perform catalysis (Mund & Pelham, 2009). Later 
on, Zhu et al., 2017 confirmed that in order to increase auto-ubiquitination of Itch, the 
Ndfip1-Itch interaction must be mediated by three PY motifs and three correspondent 
WW domains in the ligase, since the interaction affinity of each WW domain alone is not 
sufficient. They hypothesized the fourth WW, which is then “free” would be the one 
mediating substrate recruitment. The same mechanism, mediated by Ndfips holds true for 
WWP2 (Riling et al., 2015). In addition, auto-inhibition of WWP2 is relieved by another 
adaptor protein called Dvl2. The requirement of multiple WW domains to be involved in 
the process is also needed here, since Dvl2 can fulfil its function only after polymerization 
(Mund et al., 2015). For the highly related WWP1 protein not much is known; it seems that 




it becomes activated by Smad7 (Courivaud et al., 2015), as it happens for Smurf2, but how 
exactly this happens, whether Smad7 binds to the HECT or the WW1 domains was not 
addressed. A different mechanism consists of activation by Tyrosine (Tyr) phosphorylation. 
The first example was published for Itch (Gallagher et al., 2006). The mechanism involves 
the phosphorylation of two Tyr residues located in the WW2-3L, upon which the 
interaction with the HECT domain is disrupted (Zhu et al., 2017). Exactly the same strategy 
was defined for WWP2 (Chen et al., 2017). Phosphorylation also regulates Nedd4, but in 
this case the Tyr residues modified are located one in the HECT domain and the other one 
in the C2 domain, disrupting the auto-inhibition. These Tyr residues are conserved in 
many Nedd4-family members except for Smurf1 and Smurf2, precluding regulation by 
phosphorylation at these sites for these proteins (Persuad et al., 2014). Finally, the ability of 
the C2 domain to interact with specific ligands can also trigger activation of E3s, as it was 
described for Nedd4 proteins. Wang et al., 2010 showed that calcium binding to the C2 
domain disrupts the C2:HECT domain interaction, leading to activation of the protein. The 
effect of calcium was significantly enhanced by the addition of a membrane-rich fraction, 
what suggest that the mechanism in vivo probably involves the disruption of the C2:HECT 
interaction upon Ca2+ influx and the translocation to the plasma membrane. Furthermore, 
Escobedo et al., 2014, showed that the C2 domain of Nedd4L binds Ca2+ and IP3 through 
the same binding surface where the HECT domain interacts. In addition, they suggested 
that competition between IP3 and Ca2+ and the HECT domain comprises a mechanism to 
activate Nedd4L. Due to the fact that the C2 domain is present and conserved in all 
members of the Nedd4 family, Ca2+ binding might represent a general mechanism to 
release the auto-inhibition state in the Nedd4-family. 
C2 domains are independently folded modules of about 130 amino acids, present in a 
wide variety of proteins, involved mainly in signal transduction and membrane trafficking 
(Corbalan-Garcia & Gómez-Fernández, 2014). The C2 domain structure consists of a 
compact β-sandwich formed by two four-stranded β-sheets. A circular permutation 
defines the two topologies that C2 domains can adopt: class I (or S-family), where the N 
and C-t tails are located at the top of the domain (Synaptotagmins, PKCα and β) and class 
II (or P-family) where the N and C-t are located at the bottom (cPLA2, PLCs, PKC δ and ε, 
Nedd4 family) (Rizo & Südhof, 1998) (Figure 34). The top of the molecule is referred as the 
region where calcium binds to the C2 domain, and thus the bottom is located at the 
opposite site. C2 domains can bind both Ca2+ and phospholipids. Ca2+-binding is mostly 
mediated by a set of conserved Asp residues located in three loops (loop 1, 2 and 3) at 
the top of the molecule, defining the so called calcium binding region (CBR). Of note, the 
residues involved in HECT binding are also located at the top loop region. On the 
contrary, C2 domain binding to target phospholipids is achieved by a combination of 
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Figure 36. Asp and Asn residues are involved in calcium interaction. A-C) Overlay of a 
selected region of the 1H,15N-HSQC spectra of 15N-labeled Nedd4 C2 domain A) WT 
(pH=7), B) D35A and C) D41A mutants in the absence (black) and presence (lime) of an 
200-fold stoichiometric excess of CaCl2. The residues used for analysis are numbered and 
circled in red. The asterisk in C indicates that the resonance is missing. D) The plot shows, 
for each of the selected peaks, the difference in CSP before and after addition of CaCl2, 
comparing the WT Nedd4 C2 domain and two mutants: D35A and D41A. Titrations 
experiments were recorded using a pH=7 buffer. E-H) As for A-C but for Nedd4 C2 
domain E) WT (pH=7.5), F) D93A, G) N95A and H) D101A mutants. I) As D, but for Nedd4 
C2 domain WT and three mutants: D93A, N95A and D101A. Titrations experiments were 
recorded using a pH=7.5 buffer. 
 
calcium) and the final position (with calcium) was calculated as the chemical shift average. 
This analysis was performed for every mutant and the results plotted in Figure D and I. Of 
note, a buffer pH=7 was used for recording the spectra of mutants D35A and D41A and 
pH=7.5 for mutants D93A, N95A and D101A. Thus, a WT spectrum for each pH is used as 
the reference for the correspondent set of mutants. A reduction in CSP on the plot is an 
indicator of the relevance of a specific residue in Ca2+ binding, since it means that with the 
introduction of the mutation the C2 domain is less or no longer able to interact with Ca2+. 
Analyzing plots D and I, it is possible to conclude that D41 and D93 are essential for the 
C2: Ca2+ interaction, since the four peaks considered showed a significant reduction of the 
CSP or no shift at all. N95 and D35 are relevant for the interaction, showing a significant 
reduction in CSP, while D101 is not playing a relevant role since the mutation did not 
affect the binding capabilities of the WT Nedd4 C2 domain. In the case of mutant D101A 
the peak number 2 shifts more than the correspondent peak in the WT, which might 
happen due to some local rearrangement in the mutant. 
To investigate whether Ca2+-binding to the C2 domain could indeed compete with HECT 
domain binding, I recorded a 2D 1H,15N-TROSY spectra of a 15N-labeled Nedd4 HECT 
domain as reference and I added a 2-fold excess of unlabeled C2 domain to form a 
complex (Figure 37A). Next, an excess of CaCl2 was added to the sample to analyze 
whether Ca2+ would reverse the CSPs in the HECT domain that were induced by C2 
domain binding (Figure 37B). The high molecular weight of the complex (approx. 60 kDa) 
compromised the quality of the spectra. None-the-less it was possible to observed that 
the resonances that have shifted or disappeared as a consequence of the C2:HECT 
interaction, re-appear or shift back to the original position after CaCl2 was added. This 
shows that the presence of Ca2+ interferes with the HECT:C2 interaction. In sum, these 
structural data corroborates that Ca2+ binding can trigger the disruption of the auto-
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Figure 39. Solution structure of the Rsp5 C2 domain. A) Ensemble of the 10 lowest-energy 
NMR structures out of 50 structures calculated. The backbone is shown in pale green. α-
helices and β-strands are color-coded in dark green and green respectively. The NMR 
structure was solved by Vincent Truffault. B) Ribbon representation of the lowest-energy 
structure color-coded as in A. A representation of the secondary structure topology of the 
Rsp5 C2 domain is indicated on the bottom. C) Structural superposition of the Rsp5 C2 
domain (green) and the Nedd4 C2 domain (PDB:3B7Y) (purple), both belonging to the 
class II or P-family. D) Sequence alignment of Nedd4 and Rsp5 C2 domains. Identical 
residues are colored in blue and alignment gaps are indicated with a black line. A 
prediction of secondary structure elements for Rsp5 C2 domain was performed with 
Quick2D (Alva et al., 2016) and it is shown below the alignment.  
 
Additionally, it contains one short α-helix that connects β strands 6 and 7. A secondary 
structure topology is shown in Figure 39B. The overlay of the Rsp5 and Nedd4 C2 
domains (PDB ID: 3B7Y) showed that the core β sandwich fold is highly similar (Figure 
39C), although the sequence conservation is only about 28% (Figure 39D). As for Nedd4, 
Smurf1 and Smurf2, the Rsp5 C2 domain belongs to the type II family where the N and C-
t are located at the bottom of the structure. 
With all resonance assignments and structures in hand, I mapped the residues that were 
affected by Ca2+ binding onto the respective C2 domain structures. For Smurf1, the 
conserved residues D29, D35, N56 and N82 do not display CSP. I found that the largest 
(though still minor in comparison with the Nedd4 C2 domain) CSPs stem from four 
Histidine (His) residues (H49, H65, H83 and H87) (Figure 40A). Two of them (H49 and H65) 
are located outside of the CBR. The other two (H83 and H87) lie in the loop 3, one of the 
known regions for Ca2+ interaction. However, His residues are very sensitive to small pH 
changes, which can happen upon the addition of CaCl2 to the NMR sample. Smaller CSPs 
were also observed for a few other peaks (S50, N63, K84, K85, K88 and V129), but all of 
them were located next to one of the four His previously mentioned, and thus can be 
considered as indirect effects. No CSP was observed for the first loop, which is required for 
Ca2+ coordination. For Smurf2 the results were very similar to what was observed for 
Smurf1 (Figure 40B). D27 and D34, the conserved Asp residues that belong to the CBR1, 
as well as N55 from the CBR2, showed no CSP. As for Smurf1, four His residues (H48, H64, 
H82 and H86) displayed the most pronounced chemical shift changes. The latter two (H82 
and H86) are located in the CBR3, while the first two (H48 and H64) are outside any CBR. 
Smaller CSPs were observed for residues C47, N81, K83, K87 and K88, all located next to 
His. Overall, considering the small number of residues affected, the magnitude of the 
shifts, the lack of CSPs in the CBR1 and the His sensitivity to pH changes, I can conclude 
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Figure 41. Sequence structural alignment of representative C2 domains together with 
Nedd4-family C2 domains. A canonical class I C2 domain (PCK-α, boxed in blue) and one 
that belongs to the class II family (PLCδ, boxed in green) were chosen for comparison. 
Members of the Nedd4-family are boxed in yellow. The C2 domain protein sequence of 
the three regions involved in calcium binding are shown and labeled as CBR1, CBR2 and 
CBR3. The dots indicate entire regions from the sequence that were not displayed, while 
the dashes indicate a gap in the alignment. PKC-α residues involved in Ca2+ binding are 
boxed in blue, while for PLCδ is done in green. The key residues for Ca2+ coordination are 
labeled in magenta, and conserved residues in light pink. In orange are labeled other 
residues that contribute to Ca2+ binding, while conserved residues in this position are 
shown in brown. Introduction of an extra positively charged residue is indicated in bold. 
The numbering above the alignment refers to the protein sequence of Nedd4. 
 
PKC-α and PLCδ were chosen as a typical C2 domains from class I and class II respectively. 
Both of them share the main feature regarding calcium interaction: they have five Asp or 
Asn residues located in the CBR, four of which are located in the same positions. Other 
extra residues contribute to Ca2+ binding (four for PKC-α and three for PLCδ). The main 
difference is that in the class I only the CBR1 and CBR3 interact with calcium, while for C2 
domains of the class II, the third CBRs is involved in calcium binding. This is share by the 
majority of the members of each family. The amount of Ca2+ ions that each protein binds 
it also seems to be a feature of each class, three Ca2+ ions in the case of class I and two for 
class II (Figure 34). Since the Nedd4-family C2 domains belong to the class II family, it is 
expected that they are more similar to PLCδ than to PKC-α. However, the alignment of 
the CBR1 region showed that there is a high level of conservation for all the Nedd4-family 
members studied (Nedd4, Smurf1, Smurf2 and Rsp5) with PKC-α, sharing two conserved 
Asp residues in that loop. In the CBR2, class II C2 domains such as PLCδ, bear a conserved 
Asn residue that participates in Ca2+ interaction; this is displayed only in Smurf1 and 
Smurf2. Finally, according to the CBR3, the Nedd4-family members studied can be group 
in two. On the one hand, Nedd4 (as well as Nedd4L) which shows a considerably high 
conservation with respect to PKC-α, having two Asp residues conserved out of three, and 
a Asn for the third one. On the other hand, Smurf1, Smurf2 and Rsp5 are more similar 
among each other and do not show residues involved in calcium binding in the 
appropriate positions. In addition, Smurf1 and Smurf2 bear four extra positively charge 
amino acids in the CBR3, while Rsp5 three more. This might increase the overall positive 
surface potential of the domains; further diminishing Ca2+ binding capabilities. In sum, the 
lack of conservation in the key regions for Ca2+ binding (CBRs) observed for Smurf1, 
Smurf2 and Rsp5 is probably the main reason why they cannot interact with calcium. 
Other members of the Nedd4 family such as Itch and the WWP ligases do not show any 
conservation at the three CBRs, suggesting that Ca2+ interaction is not involved in the 
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Figure 42. Calcium coordination of Nedd4 C2 domain in comparison with canonicals class 
I and II C2 domains. The color code is the same used in Figure 34. Nedd4 is color in red 
and the Ca2+ ions in lime. A) Ribbon representation of the CBR region of PKC-α C2 
domain (PDB ID: 1DSY). The tree Ca2+ ions are indicated in the structure.  B) As A but for 
Nedd4 C2 domain (PDB ID: 3B7Y). The arrows indicate a loop which is missing in the 
crystal structure. C) Structural superposition of PKC-α and Nedd4 C2 domains. D) As A but 
for PLCδ C2 domain (PDB ID: 1DJI). The arrows indicate a loop which is missing in the 
crystal structure. E) As B but aligned to overlap with PLCδ. F) Structural superposition of 
PLCδ and Nedd4 C2 domains. 
 
Interestingly, a superposition of PLCδ and Nedd4 C2 domains (Figure 42F) shows that 
Nedd4 binds one Ca2+ ion in position Ca1, while the other does not seem to be in position 
Ca4 either. Whether Nedd4 C2 domain coordinates Ca2+ ions in a different why from both 




 The Nedd4 C2 domain binds Ca2+ through conserved residues in the CBR and this 
interaction interferes with HECT domain binding.  
 On the contrary, the C2 domains of Smurf1, Smurf2 and Rsp5 are not able to bind 
Ca2+. 
 Ca2+-mediated Ub ligase activation thus does not play a role in Smurf1, Smurf2 
and Rsp5. According to the structural alignment Itch, WWP1 and WWP2 are also 
probably not regulated by this mechanism that seems to be restricted to a small 
subset of Nedd4-family proteins. 
 The lack of conservation in the CBR of Smurf1, Smurf2 and Rsp5 C2 domain is 
probably the main cause to explain why they are not able to coordinate Ca2+. 
 Nedd4 C2 domain might bind Ca2+ differently from the canonical members of class 
I and class II C2 domains.  
4.3.4 Discussion 
 
Several studies have addressed how Nedd4-family Ub ligases avoid untimely targeting of 
themselves or substrates by adopting an auto-inhibited conformation. It is thus important 
to understand how these ligases are activated in order to fulfill their functions. Previous 
studies (Escobedo et al., 2014; Wang et al., 2010) have shown that Ca2+ triggers activation 
of Nedd4 proteins.  Ca2+ binding to the C2 domain relocate the Ub ligase to the plasma 
membrane, leaving the HECT domain in a “free” state, ready to perform catalysis. In this 
study I classified different C2 domains of Nedd4-family proteins regarding their Ca2+ 




binding capabilities in order to evaluate how conserved this activation mechanism is within 
the Nedd4-family.  
My NMR analysis show that, as Nedd4L, the Nedd4 C2 domain interacts with Ca2+ 
involving conserved residues located in the CBR. This is in agreement with the Nedd4 C2 
structure, which co-crystalize with two Ca2+ ions (PDB ID: 3B7Y). In addition, I could show 
that peaks in the Nedd4 HECT domain that display CSPs upon C2 domain binding, reverse 
to the free state upon addition of Ca2+ to the HECT:C2 complex. This demonstrates that 
the C2 domain interacts both with the HECT domain and with Ca2+ through the same or at 
least a partially overlapping binding surface. This finding is consistent with results 
published by Escobedo et al., 2014, where the Nedd4L C2:HECT interaction was shown to 
dissociate in presence of Ca2+. In contrast, Smurf1, Smurf2 and Rsp5 are not able to bind 
Ca2+, therefore the mechanism of C2 release from the HECT domain that is triggered by 
Ca2+ does not play a role in their activity regulation. The small CSPs observed for their C2 
domains upon calcium addition, are displayed mainly by residues located outside the CBR 
and especially near His, which are prone to be affected by small pH changes. Among 
Smurf1, Smurf2 and Rsp5 the most conserved with respect to a canonical C2 domain is 
Rsp5 (Figure 41). The fact that this domain, being the most conserved and possessing no 
His residue, is the one that shows less CSPs upon Ca2+ binding, supports the idea that the 
CSPs observed for Smurf1 and Smurf2 were not significant, but stem from changes 
induced by His residues. 
The structural alignment based on the protein sequence of C2 domains (Figure 41) allows 
the understanding of some differences inside the Nedd4-family. The only two members 
that displayed a considerably high level of sequence conservation concerning the Asp/Asn 
residues in the CBRs, are the ones that can bind calcium: Nedd4 and Nedd4L. The other 
three studied proteins Smurf1, Smurf2 and Rsp5, showed less conservation, in particular 
concerning the CBR3. Indeed, CBR3 might be more relevant in terms of C2-Ca2+ 
interaction, since for PKC-α for example, the Asp residues belonging to the CBR3 are 
involved in the interactions with all Ca2+ ions (Ca1, Ca2 and Ca3) while the Asp residues in 
CBR1 participate in the coordination of only Ca1 and Ca2. Considering the CBR3, Smurf1, 
Smurf2 and Rsp5 are really similar among them, but not to the canonical C2 domains.  
Nedd4 seems to share features with both classes of C2 domains; its topology corresponds 
to class II, though, its sequence conservation is higher with respect to class I C2 domains 
(Table 5). 
 
Table 5. Nedd4 C2 domain shows more conservation to canonical members of class I than 
to class II C2 domains. Identical and similar residue percentages for Nedd4 C2 domain, in 
comparison to two of the canonical C2 domains of each class are shown. The alignment 
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5. General discussion 
 
Ubiquitination is a PTM that plays a role in virtually every cellular process by guiding the 
fate of hundreds of proteins inside the cell and is therefore crucial for cell homeostasis. 
Among the enzymes involved in this pathway, E3s stand out mainly for one reason: they 
define the specificity of the reaction. In other words, they choose the E2 from which they 
receive the Ub, and select the substrate which is going to be modified, thereby 
determining the outcome of the reaction. To date, it is estimated that the human genome 
encodes about 600 E3s, what helps to explain ubiquitination comprehensiveness. From 
those E3s, only 28 belong to the HECT family, whose main feature is their ability to form 
an Ub~thioester intermediate before they transfer Ub to the substrate. In my thesis, I 
focused on the Nedd4-family of HECT ligases, which has nine members in humans. Due to 
their relatively small size (~100 kDa) in comparison with other E3s and the high 
conservation level of their members, they form an interesting group of enzymes to study 
and characterize the mechanism of ubiquitination. In addition, Nedd4-family members 
have been associated with several human diseases; e.g. they play preponderant roles in 
cancer acting both as tumor suppressors or oncoproteins (Zou et al., 2015).  
In view of their significance and the potential impact of their activity inside the cell, E3 
ligases in general and Nedd4 E3s in particular, must be tightly regulated to avoid targeting 
themselves and/or their substrates unless it is required. E3 activity can be regulated at 
different levels including: E2 recruitment, substrate interaction, E3 processivity and through 
intermolecular as well as intramolecular interactions (Mari* Ruetalo* et al., 2014). In the 
case of the Nedd4-family, it is now clear that intramolecular interactions are essential for 
their regulation. When I started my PhD only a few examples of intramolecular interactions 
participating in activity regulation were available. The pioneer work published in Wiesner 
et al., 2007 established that Smurf2, one of the Nedd4-family members, is regulated by an 
intramolecular interaction between the C2 domain and the HECT domain that causes 
auto-inhibition of the enzyme. Itch was also described to be auto-inhibited, but through a 
different interaction, mediated by the WW and the HECT domains (Gallagher et al., 2006). 
Later, Wang et al., 2010 showed from a functional perspective that Need4 and Nedd4L 
are also auto-inhibited. In this context, the first part of my thesis (chapter 4.1) dealt with 
the molecular basis of the auto-inhibition mechanism in Smurf2 and Nedd4. Using 
structural and functional approaches I was able to explain how the C2:HECT auto-
inhibitory mechanism works: The C2 domain binds to the HECT domain on a surface 
mapped in Mari*Ruetalo* et al., 2014, and this binding not only locks the HECT domain in 
a catalytically incompetent conformation where it cannot receive the Ub from the E2 
(Figure 14), but also buries the UBS by partial surface overlapping, abolishing non-




covalent Ub binding (Figure 11 C-D, 12). These two events maintain FL Smurf2 and Nedd4 
in an inhibited conformation, although a full inactivation is not reached (discussed further 
below). Of note, the same conclusions were obtained both for Smurf2 and Nedd4, 
showing a high level of conservation between these two ligases. 
In the next couple of years, evidence was mounting that both the C2 domains and the 
WW-linker regions are involved in the regulation of many other members of the family 
(Chen et al., 2017; Courivaud et al., 2015; Mari* Ruetalo* et al., 2014; Mund et al., 2015; 
Riling et al., 2015; Zhu et al., 2017). All of them are described as being auto-inhibited. 
Differently from what was thought at the beginning of my work, the inhibition mechanism 
is not exactly the same for all the Nedd4-family members, but they have developed 
slightly protein-specific differences. Roughly, considering which domains mediate 
inhibition, two groups can be distinguished: A) C2-mediated inhibition, to which Smurf2, 
Nedd4 and Nedd4L belong, as already discussed and B) WW2-3L-mediated inhibition, as 
described for Itch, WWP1 and WWP2. Here, the inhibition is mediated by the interaction 
of a α-helix located in the linker between the WW2 and WW3 domain, which basically 
causes the same effect that the C2 domain does. It blocks the HECT domain and impairs 
E2-E3 transthiolation while part of the WW2 and the following linker partially occupy the 
UBS (Figure 16). A structural comparison as published in Zhu et al., 2017, shows that the 
residues in the HECT domain involved in auto-inhibition either in group A or B overlap 
with the UBS. However, these residues involved in auto-inhibition are not conserved 
among every member of the family, but just within each group. This helps to explain why 
Smurf2, Nedd4 and Nedd4L on one side and Itch, WWP1 and WWP2 on the other have 
common mechanisms.  
This overview about the different proteins and mechanisms of the Nedd4-family does not 
include another relevant member, Smurf1. Few published studies are available (Lu et al., 
2011; Courivaud et al., 2015; Mund et al., 2015; Wan et al., 2011) and no agreement about 
whether it is auto-inhibited was established. Therefore, I decided to study the activity and 
potential regulation of Smurf1 (Chapter 4.2). Considering the high level of sequence 
conservation with the related Smurf2 enzyme (Figure 17) one would assume that the 
C2:HECT auto-inhibition mechanism should be conserved between Smurf2 and Smurf1. 
Indeed, my results show that the Smurf1 HECT domain is able to interact with the C2 
domain and Ub in a non-covalent manner (Figure 18, 22A, 23A). Both binding surfaces are 
partially overlapping on the HECT domain and are well conserved with respect to their 
Smurf2 counterparts (Figure 20, 22B-C, 23B-C). In addition, competition assays (Figure 26) 
showed that the Smurf1 C2 domain can inhibit HECT domain activity in trans. However, in 
auto-ubiquitination assays, Smurf1 FL was highly active, with the deletion of the C2 
domain barely having an effect (Figure 25), consistent with other reports (Lu et al., 2011; 
Courivaud et al., 2015; Mund et al., 2015). Altogether, this shows that Smurf1 is the only 




member of the family which is not regulated by an auto-inhibitory mechanism, at least in 
vitro. Given the relevance of E3 activity regulation in cells, it is reasonable to assume that a 
mechanism to regulate Smurf1 activity must be present in the cell, which is missing in vitro, 
such as the presence of specific proteins to inhibit Smurf1 or differential activity depending 
on cellular localization. Indeed, Lu et al., 2011 shows that the C2 domain has a role in 
Smurf1 localization to the plasma membrane, since deletion of the C2 domain changed it 
localization from being membrane-associated to a cytoplasmic distribution. Moreover, the 
C2 domain could also be involved in substrate selection. This proposed role for the C2 
domain still awaits further structural evidence. PTMs are also linked to Smurf1 regulation; 
Cheng et al., 2011 showed that PKA dependent phosphorylation of Smurf1 can affect its 
affinity to substrates, reducing ubiquitination of some of them and increasing it for others. 
Finally, a potential mechanism of inhibition could be abolishing binding to its targets by 
blocking the WW domains, as it was described to happen when LMP-1 binds to Smurf1 
(Cao & Zhang, 2013). 
From a sequence point of view, the major difference between Smurf1 and Smurf2 is the 
linker region, between the C2 and the HECT domains, in particular the lack of one WW 
domain in Smurf1. The analysis of chimeric proteins (Figure 27), where the entire linker 
region was swapped, showed activation of Smurf2 and inhibition of Smurf1. In addition, 
the deletion of the WW1 domain from Smurf2 also activates the protein, but less efficiently 
(Figure 28). These results confirm the potential of the Smurf1 C2 domain to exert inhibition 
and led me to the conclusion that the Smurf1 linker does not allow for auto-inhibition, 
with the WW1 domain playing an important role in mediating C2:HECT inhibition. The 
Smurf2 WW1 domain was reported not to interact with the HECT domain (Wiesner et al., 
2007) and our own results showed that it is not able to interact directly with the C2 
domain either (Figure 29). I hypothesized then, that the Smurf2 WW1 domain might help 
the C2 domain to orient itself to perform inhibition. My NMR results showed indeed that 
the presence of the linker-WW1 fragment together with the C2 domain in an entire entity 
(C2-linker-WW1) changed the way in which the C2 domain interacts with the HECT 
domain, increasing the binding affinity ~20X (Figure 30). In addition, the effect of the 
Smurf2 linker-WW1 was confirmed in competition assays, where the HECT domain 
inhibition was strikingly higher for the C2-linker-WW1 than for the C2 domain alone 
(Figure 32). Analyzing the CSPs for the C2-linker-WW1 domains compared with the C2 
domain and the linkerWW1 fragment, allowed me to map an interaction surface between 
the C2 domain and the C2-WW1L (Figure 31). Taken all the data together, I proposed a 
model where the interaction between the Smurf2 C2 domain and the C2-WW1L orients 
the WW1 domain to reach the HECT domain to inhibit its activity, together with the C2 
domain. The C2-WW1L residues involved in the interaction with the C2 domain are quite 
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region of 17, 41 and 40 residues respectively, and enzymes in group B) that is composed 
of WWP1, WWP2 and Itch, where the first WW1 domain is far from the C2 domain having 
linker regions of 210, 159 and 148 residues respectively. Thus, I speculate that the number 
and location of the WW domains for each member determines a particular spatial 
configuration of domains, which facilitates that the C2 domain reaches the HECT domain 
(group A, Figure 44A) or alternatively the WW2-3L (group B, Figure 44B) fulfils this 
function. Finally, HECW1 and HECW2 contain only two WW domains like Smurf1, but on 
the contrary, they are double-size and carry a different domain distribution, what makes it 
difficult to predict what could happen in their cases. 
Another aspect of regulation concerns enzyme activation. Since Nedd4-family members 
are kept in an inhibited conformation, they need a mechanism to release it. Basically, three 
main mechanisms have been described and all consist of different strategies to disrupt the 
interaction between the C2 domain or the WW2-3L region and the HECT domain. One of 
them involves adaptor proteins, which bind to the HECT domain and out-compete the 
inhibitory domain(s). This is the case for Smurf2, where Smad7 controls the E3 activity at 
multiple levels. It binds to the HECT domain disrupting the C2 domain binding and at the 
same time, recruits the E2 facilitating transthiolation (Ogunjimi et al., 2005). Activation by 
adaptor binding also happens for Itch and Nedd4, which interact with the adaptor protein 
NDFIP1-2 through their WW domains to release the HECT domain (Mund & Pelham, 
2009). This strategy was also described for WWP2 and the protein Dvl2; upon Dvl2 
polymerization it binds to the WW domains disrupting the interaction with the HECT 
domain and promoting HECT activity (Mund et al., 2015). For WWP1 not much is known; 
Courivaud et al., 2015 claims that it is activated by Smad7, but it is not clear whether this 
protein binds to the C2 or to the WW domains. A second mechanism is release of auto-
inhibition through phosphorylation. The first example was described early on for Itch; 
phosphorylation of three residues in a Pro rich region activates the enzyme (Gallagher et 
al., 2006, Zhu et al., 2017). WWP2 was also found to be regulated by phosphorylation, 
when two Tyr residues present in the WW2-3L are modified the enzyme becomes active 
(Chen et al., 2017). Tyr phosphorylation in the HECT and the C2 domain disrupts their 
interaction for Nedd4, resulting in an active HECT domain (Persuad et al., 2014). Finally, a 
third mechanism, described for Nedd4 enzymes, is the Ca2+-mediated C2 disruption and 
re-localization to the plasma membrane (Wang et al., 2010).  
The overview of the different activation mechanism shows, that different from the auto-
inhibition, it is not possible to group them according to particular features of each 
member. It seems that every protein can be subject to any of these activating 
mechanisms, as is the case for Nedd4 that is regulated by an adaptor protein, a PTM and 
Ca2+ influx. In this context, I studied the third mechanism described here, Ca2+-mediated 
release of the C2 domain within the Nedd4 family (Chapter 4.3). My results confirm that 




the Nedd4 C2 domain can interact with Ca2+ in solution (Figure 35, 36) through the 
conserved Asp and Asn residues located in the CBR. Also, I showed that the addition of 
CaCl2 to the C2:HECT complex disrupts their binding (Figure 37). The NMR analysis of 
Smurf1, Smurf2 and Rsp5 (the yeast homolog to Nedd4) revealed that these C2 domains 
are not able to bind Ca2+ (Figure 38) and therefore most likely are not regulated by this 
mechanism. Ca2+-mediated C2 release is thus restricted to Nedd4 and Nedd4L. From a 
structural alignment considering the CBR region from all Nedd4-family members (Figure 
41), it is possible to explain that Smurf1, Smurf2 and Rsp5 do not coordinate Ca2+ as a 
consequence of loss of conservation in the CBR3. The other three members (Itch, WWP1 
and WWP2) do not show any conservation in this region, reason why they were not 
included in the study. Of note, neither of them is inhibited by a C2-mediated mechanism, 
thus it is possible to speculate that the conservation of this region is less relevant for them, 
since an activation mechanism involving the C2 domain might not be useful.   
As final considerations, the results of this thesis underline the relevance of performing 
detailed studies about the molecular mechanisms that govern the activity of individual 
proteins, even within a family such as the Nedd4-family of E3s, which display a remarkably 
high level of conservation in sequence, structure and domain organization. Huge activity 
differences as I found between Smurf1 (fully active) and Smurf2 (inhibited), in proteins that 
share more than 70% of amino acid sequence, were highly unexpected. Moreover, since 
these enzymes lie at the cross road between tumor suppression and oncogenesis, as well 
as other pathologies, understanding their differential regulation might be helpful for the 
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Figure S1. Full view spectra of titration experiments used for mapping interaction surfaces 
and Kd determination. 1H,13C-methyl TROSY spectra using either an ILVAM-labeled sample 
(A) or IM-labeled of Smurf1 HECT domain (B-E). All residues involved in the interactions 
are assigned and labeled. A) Smurf1 HECT domain in the absence and presence of 
equimolar or increasing amounts of Smurf1 C2 domain (four-fold and 12-fold 
stoichiometric excess). B) Smurf1 HECT domain in the absence and presence of increasing 
amounts of Ub (1.5-fold, six-fold and 15-fold stoichiometric excess). C) Smurf2 HECT 
domain in the absence and presence of equimolar or increasing amounts of Smurf2 C2 
domain (four-fold and 12-fold stoichiometric excess). D) Smurf1 HECT domain in the 
absence and presence of increasing amounts of Ub (1.5-fold, six-fold and 15-fold 
stoichiometric excess). E) Smurf2 HECT domain in the absence and presence of half 
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